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I.  General Information 
 
The following reagents were purchased and used as received: CuI (Aldrich, 98%), n-Bu4NI 
(Aldrich), K2CO3 (Amresco, anhydrous), t-butyl propiolate (TCI America), methyl propiolate 
(Aldrich), 4-methoxybenzyl chloride (Aldrich), benzyl chloride (Aldrich), 4-chlorobenzyl 
chloride (Aldrich), 2-methylbenzyl chloride (Aldrich), 1-(chloromethyl)naphthalene (Alfa 
Aesar), 2-(chloromethyl)naphthalene (Alfa Aesar), 4-methoxybenzyl alcohol (Aldrich), benzyl 
alcohol (Aldrich), 4-(trifluoromethyl)benzyl alcohol (Aldrich), allyl alcohol (Aldrich), propargyl 
alcohol (Aldrich), methyl glycolate (Aldrich), methanol (Aldrich, anhydrous), 1-pentanol 
(Aldrich), 2-(trimethysilyl)ethanol (Aldrich), cyclohexanemethanol (Aldrich), (S)-1-
phenylethanol (Alfa Aesar, >99% ee), (R)-1-phenylethanol (Alfa Aesar, >99% ee), rac-1-
phenylethanol (Aldrich), (S)-SITCP ((S)-1, Strem, >99% ee), (R)-SITCP ((R)-1, Strem, >99% ee), 
PhMgBr (Aldrich; 3.0 M in Et2O), CuBr·SMe2 (Acros), HMPA (Aldrich), TMSCl (Aldrich), AD-
mix-β (Aldrich), methanesulfonamide (TCI America), and DDQ (Acros).  N,N-
Dimethylpropiolamide and the remaining benzylic chlorides (for alkyne synthesis) have been 
reported previously and were synthesized according to literature procedures.  Toluene, 
acetonitrile, and dichloromethane were deoxygenated and dried by sparging with nitrogen 
followed by passage through an activated alumina column (S. G. Water) prior to use. 
1H and 13C NMR spectroscopic data were collected on a Varian 500 MHz spectrometer at 
ambient temperature, and 31P NMR spectroscopic data were collected on a Varian 400 MHz 
spectrometer at ambient temperature.  HPLC analyses were carried out using an Agilent 1100 
Series system with Daicel CHIRALPAK® columns (internal diameter 4.6 mm, column length 
25.0 cm, particle size 5 µm). 
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II.  Synthesis of Alkynes and Allenes 
 
Alkynes: The alkynes were synthesized according to a procedure modified from a literature 
report for the synthesis of similar compounds.1  The yields have not been optimized. 
 
Procedure A.  An oven-dried round-bottom flask with a stir bar was charged with CuI (1.00 
equiv) and K2CO3 (2.00 equiv).  The flask was placed under a nitrogen atmosphere, and then 
anhydrous acetonitrile (to generate a 0.2 M solution of the benzyl chloride) was added via 
syringe.  Next, the benzyl chloride (1.00 equiv) was added via syringe (if the benzyl chloride 
was a solid, it was added before the flask was placed under nitrogen), followed by t-butyl 
propiolate (2.00 equiv).  The reaction mixture was stirred at room temperature for 48 h, and then 
the reaction was quenched with saturated aqueous NH4Cl (same volume as the acetonitrile).  
The reaction mixture was extracted twice with Et2O, and the combined organic extracts were 
dried over anhydrous Na2SO4, filtered, and concentrated.  The resulting residue was purified by 
column chromatography. 
 
Procedure B.  An oven-dried round-bottom flask with a stir bar was charged with CuI (1.00 
equiv), K2CO3 (1.00 equiv), and n-Bu4NI (1.00 equiv).  The flask was placed under a nitrogen 
atmosphere, and then anhydrous acetonitrile (to generate a 0.2 M solution of the benzyl 
chloride) was added via syringe.  Next, the benzyl chloride (1.00 equiv) was added via syringe 
(if the benzyl chloride was a solid, it was added before the flask was placed under nitrogen), 
followed by t-butyl propiolate (2.00 equiv).  The reaction mixture was heated to 40 °C and 
stirred for 48 h.  Next, it was quenched with saturated aqueous NH4Cl (same volume as the 
acetonitrile).  The reaction mixture was extracted twice with Et2O, and the combined organic 
extracts were dried over anhydrous Na2SO4, filtered, and concentrated.  The resulting residue 




tert-Butyl 4-phenylbut-2-ynoate.  The title compound was synthesized according to 
Procedure B from t-butyl propiolate (1.40 g, 11.1 mmol), benzyl chloride (700 mg, 5.53 mmol), 
CuI (1.05 g, 5.53 mmol), K2CO3 (764 mg, 5.53 mmol), and n-Bu4NI (2.04 g, 5.53 mmol).  The 
product was purified by column chromatography on silica gel (2→4% Et2O/hexanes), which 
furnished the title compound (928 mg, 78%) as a pale-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.36–7.24 (m, 5H), 3.72 (s, 2H), 1.50 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.9, 134.5, 128.9, 128.2, 127.2, 84.0, 83.4, 76.2, 28.1, 25.1. 
FT-IR (neat) 2980, 2242, 1706, 1496, 1477, 1454, 1419, 1394, 1369, 1279, 1258, 1159, 1079, 1066, 
1032, 844, 754, 732 cm–1. 





tert-Butyl 4-(4-methoxyphenyl)but-2-ynoate.  The title compound was synthesized 
according to Procedure A from t-butyl propiolate (3.22 g, 25.6 mmol), 4-methoxybenzyl chloride 
(2.00 g, 12.8 mmol), CuI (2.44 g, 12.8 mmol), and K2CO3 (3.54 g, 25.6 mmol).  The product was 
purified by column chromatography on silica gel (7.5→10% Et2O/hexanes), which furnished the 
title compound (2.88 g, 91%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.25–7.21 (m, 2H), 6.89–6.84 (m, 2H), 3.80 (s, 3H), 3.65 (s, 2H), 
1.50 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 158.8, 153.0, 129.2, 126.5, 114.3, 84.5, 83.3, 76.0, 55.5, 28.1, 24.3. 
FT-IR (neat) 2980, 2935, 2837, 2241, 1703, 1699, 1612, 1587, 1514, 1463, 1456, 1422, 1394, 1370, 
1250, 1159, 1069, 1034, 844, 812, 755 cm–1. 




tert-Butyl 4-(4-chlorophenyl)but-2-ynoate.  The title compound was synthesized according 
to Procedure B from t-butyl propiolate (785 mg, 6.22 mmol), 4-chlorobenzyl chloride (500 mg, 
3.11 mmol), CuI (592 mg, 3.11 mmol), K2CO3 (430 mg, 3.11 mmol), and n-Bu4NI (1.15 g, 3.11 
mmol).  The product was purified by column chromatography on silica gel (2.5% Et2O/hexanes), 
which furnished the title compound (593 mg, 76%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.31 (d, 2H, J = 7.5 Hz), 7.26 (d, 2H, J = 6.5 Hz), 3.68 (s, 2H), 1.50 
(s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.8, 133.2, 132.9, 129.5, 129.0, 83.6, 83.2, 76.5, 28.1, 24.6. 
FT-IR (neat) 2980, 2241, 1705, 1492, 1457, 1408, 1395, 1369, 1280, 1257, 1158, 1092, 1069, 1016, 
844, 796, 754 cm–1. 




tert-Butyl 4-(2-methoxyphenyl)but-2-ynoate.  The title compound was synthesized 
according to Procedure B from t-butyl propiolate (1.61 g, 12.8 mmol), 2-methoxybenzyl chloride 
(1.00 g, 6.40 mmol), CuI (1.22 g, 6.40 mmol), K2CO3 (885 mg, 6.40 mmol), and n-Bu4NI (2.36 g, 
6.40 mmol).  The product was purified by column chromatography on silica gel (5→8% 
Et2O/hexanes), which furnished the title compound (1.38 g, 88%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.45–7.41 (m, 1H), 7.25 (dt, 1H, J = 1.5, 8.0 Hz), 6.96 (dt, 1H, J = 
1.0, 7.5 Hz), 6.85 (dd, 1H, J = 0.5, 8.0 Hz), 3.84 (s, 3H), 3.68 (s, 2H), 1.50 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 156.8, 153.0, 129.2, 128.5, 122.9, 120.7, 110.2, 84.4, 83.2, 76.1, 
55.5, 28.2, 19.6. 
 S–4 
FT-IR (neat) 3003, 2979, 2937, 2838, 2241, 1703, 1699, 1601, 1591, 1495, 1464, 1439, 1394, 1369, 
1282, 1249, 1158, 1108, 1069, 1050, 1029, 845, 753 cm–1. 




tert-Butyl 4-(o-tolyl)but-2-ynoate.  The title compound was synthesized according to 
Procedure B from t-butyl propiolate (1.26 g, 9.96 mmol), 2-methylbenzyl chloride (700 mg, 4.98 
mmol), CuI (948 mg, 4.98 mmol), K2CO3 (688 mg, 4.98 mmol), and n-Bu4NI (1.84 g, 4.98 mmol).  
The product was purified by column chromatography on silica gel (3→5% Et2O/hexanes), 
followed by column chromatography on reverse-phase C-18 silica gel (5→100% 
acetonitrile/water), which furnished the title compound (1.09 g, 95%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.39–7.34 (m, 1H), 7.22–7.14 (m, 3H), 3.64 (s, 2H), 2.33 (s, 3H), 
1.50 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.9, 136.2, 132.8, 130.4, 128.7, 127.5, 126.5, 83.7, 83.3, 76.3, 
28.1, 23.3, 19.5. 
FT-IR (neat) 2980, 2239, 1705, 1494, 1478, 1463, 1394, 1369, 1278, 1258, 1157, 1105, 1069, 1033, 
844, 754, 740 cm–1. 




tert-Butyl 4-(naphthalen-1-yl)but-2-ynoate.  The title compound was synthesized according 
to Procedure B from t-butyl propiolate (997 mg, 7.90 mmol), 1-(chloromethyl)naphthalene (698 
mg, 3.95 mmol), CuI (752 mg, 3.95 mmol), K2CO3 (546 mg, 3.95 mmol), and n-Bu4NI (1.46 g, 3.95 
mmol).  The product was purified by column chromatography on silica gel (2→5% 
Et2O/hexanes), which furnished the title compound (1.00 g, 95%) as a viscous pale-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.97 (d, 1H, J = 8.5 Hz), 7.89 (d, 1H, J = 7.5 Hz), 7.80 (d, 1H, J = 
8.0 Hz), 7.63–7.49 (m, 3H), 7.45 (dd, 1H, J = 7.5, 8.0 Hz), 4.12 (s, 2H), 1.51 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.9, 133.8, 131.4, 130.3, 128.9, 128.2, 126.6, 126.3, 126.1, 125.7, 
123.2, 83.6, 83.4, 77.0, 28.1, 23.0. 
FT-IR (neat) 3049, 2979, 2933, 2238, 1705, 1598, 1511, 1477, 1457, 1420, 1395, 1369, 1278, 1257, 
1156, 1082, 1031, 843, 791, 777, 754 cm–1. 





tert-Butyl 4-(naphthalen-2-yl)but-2-ynoate.  The title compound was synthesized according 
to Procedure B from t-butyl propiolate (1.07 g, 8.50 mmol), 2-(chloromethyl)naphthalene (750 
mg, 4.25 mmol), CuI (809 mg, 4.25 mmol), K2CO3 (587 mg, 4.25 mmol), and n-Bu4NI (1.57 g, 4.25 
mmol).  The product was purified by column chromatography on silica gel (2→5% 
Et2O/hexanes), which furnished the title compound (861 mg, 76%) as a pale-yellow solid. 
1H NMR (500 MHz, CDCl3) δ 7.85–7.78 (m, 4H), 7.52–7.44 (m, 2H), 7.42 (dd, 1H, J = 1.5, 8.5 
Hz), 3.88 (s, 2H), 1.52 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.9, 133.6, 132.6, 131.9, 128.6, 127.8, 126.7, 126.5, 126.4, 126.0, 
83.9, 83.4, 76.5, 28.2, 25.3. 
FT-IR (neat) 3055, 2979, 2933, 2240, 1702, 1636, 1601, 1509, 1477, 1457, 1412, 1394, 1369, 1277, 
1159, 1125, 1069, 1033, 844, 813, 754 cm–1. 




tert-Butyl 4-(thiophen-2-yl)but-2-ynoate.  The title compound was synthesized according to 
Procedure B from t-butyl propiolate (997 mg, 7.90 mmol), 2-(chloromethyl)thiophene (524 mg, 
3.95 mmol), CuI (752 mg, 3.95 mmol), K2CO3 (546 mg, 3.95 mmol), and n-Bu4NI (1.46 g, 3.95 
mmol).  The product was purified by column chromatography on silica gel (2.5% Et2O/hexanes), 
which furnished the title compound (684 mg, 78%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.20 (dd, 1H, J = 1.0, 5.0 Hz), 7.01–6.97 (m, 1H), 6.95 (dd, 1H, J = 
3.5, 5.0 Hz), 3.88 (d, 2H, J = 1.0 Hz), 1.50 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.7, 136.4, 127.2, 126.1, 124.9, 83.5, 82.7, 75.8, 28.1, 20.0. 
FT-IR (neat) 3109, 2980, 2933, 2244, 1705, 1478, 1458, 1437, 1414, 1394, 1369, 1280, 1258, 1159, 
1113, 1079, 1065, 1033, 845, 754, 700 cm–1. 




tert-Butyl 4-(thiophen-3-yl)but-2-ynoate.  The title compound was synthesized according to 
Procedure B from t-butyl propiolate (1.90 g, 15.1 mmol), 3-(chloromethyl)thiophene (1.00 g, 7.54 
mmol), CuI (1.44 g, 7.54 mmol), K2CO3 (1.04 g, 7.54 mmol), and n-Bu4NI (2.75 g, 7.54 mmol).  The 
product was purified by column chromatography on silica gel (2.5→5% Et2O/hexanes), which 
furnished the title compound (1.51 g, 90%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.30 (dd, 1H, J = 3.0, 5.0 Hz), 7.20–7.16 (m, 1H), 7.02 (dd, 1H, J = 
1.0, 4.5 Hz), 3.70 (d, 2H, J = 1.0 Hz), 1.51 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.9, 134.3, 127.7, 126.4, 122.2, 83.6, 83.4, 75.7, 28.1, 20.2. 
 S–6 
FT-IR (neat) 3105, 2980, 2933, 2244, 1703, 1478, 1460, 1418, 1394, 1369, 1302, 1274, 1258, 1161, 
1070, 1034, 938, 844, 770, 754 cm–1. 




tert-Butyl 4-(1-tosyl-1H-indol-5-yl)but-2-ynoate.  The title compound was synthesized 
according to Procedure B from t-butyl propiolate (1.03 g, 8.13 mmol), 5-(chloromethyl)-1-tosyl-
1H-indole (1.30 g, 4.06 mmol), CuI (773 mg, 4.06 mmol), K2CO3 (561 mg, 4.06 mmol), and n-
Bu4NI (1.50 g, 4.06 mmol), except that the reaction was heated to 60 °C and run for 24 h.  The 
product was purified by column chromatography on silica gel (10→15% EtOAc/hexanes) 
followed by a second column on silica gel (85% CH2Cl2/hexanes), which furnished the title 
compound (1.31 g, 79%) as a pale-yellow solid. 
1H NMR (500 MHz, CDCl3) δ 7.93 (d, 1H, J = 8.5 Hz), 7.77–7.72 (m, 2H), 7.56 (d, 1H, J = 3.5 
Hz), 7.48 (q, 1H, J = 1.0 Hz), 7.25–7.20 (m, 3H), 6.62 (dd, 1H, J = 1.0, 3.5 Hz), 3.75 (s, 2H), 2.34 (s, 
3H), 1.49 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.9, 145.1, 135.3, 134.0, 131.3, 130.1, 129.5, 127.1, 126.9, 124.9, 
120.8, 113.8, 109.0, 84.2, 83.4, 76.2, 28.1, 25.0, 21.7. 
FT-IR (neat) 3143, 3116, 2980, 2931, 2241, 1703, 1596, 1460, 1446, 1394, 1370, 1306, 1275, 1219, 
1188, 1173, 1139, 1093, 1069, 995, 844, 813, 797, 762, 725 cm–1. 




4-(4-Methoxyphenyl)-N,N-dimethylbut-2-ynamide.  The title compound was synthesized 
according to Procedure B from N,N-dimethylpropiolamide (1.17 g, 12.0 mmol), 4-
methoxybenzyl chloride (0.79 mL, 6.00 mmol), CuI (1.14 g, 6.00 mmol), K2CO3 (829 mg, 6.00 
mmol), and n-Bu4NI (2.22 g, 6.00 mmol), except that the reaction was heated to 45 °C and run for 
4 days.  The product was purified by column chromatography on silica gel (40→50% 
EtOAc/hexanes) followed by column chromatography on reverse-phase C-18 silica gel 
(10→100% CH3CN/water), which furnished the title compound (944 mg, 72%) as an orange oil. 
1H NMR (500 MHz, CDCl3) δ 7.25–7.21 (m, 2H), 6.88–6.83 (m, 2H), 3.80 (s, 3H), 3.71 (s, 2H), 
3.20 (s, 3H), 2.97 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 158.7, 154.7, 129.1, 126.9, 114.2, 90.7, 75.6, 55.4, 38.5, 34.2, 24.6. 
FT-IR (neat) 3032, 3003, 2932, 2836, 2249, 2215, 1637, 1586, 1511, 1461, 1442, 1395, 1335, 1303, 
1267, 1248, 1179, 1108, 1046, 1033, 907, 814, 753, 733, 718 cm–1. 





Methyl 4-(4-methoxyphenyl)but-2-ynoate [445234-72-0].  The title compound was 
synthesized according to Procedure A from methyl propiolate (1.08 g, 12.8 mmol), 4-
methoxybenzyl chloride (1.00 g, 6.40 mmol), CuI (1.22 g, 6.40 mmol), and K2CO3 (1.77 g, 12.8 
mmol).  The product was purified by column chromatography on silica gel (7.5→10% 
Et2O/hexanes), which furnished the title compound (1.14 g, 87%) as a yellow oil. 
 
Allenes: The yields have not been optimized. 
 
 
tert-Butyl 4-phenylbuta-2,3-dienoate [1335104-19-2].  An oven-dried 200 mL flask with a stir 
bar was evacuated and back-filled with nitrogen (3 cycles).  Next, 1-phenyl-2-propyn-1-ol (2.76 
mL, 22.7 mmol) was added via syringe, followed by THF (50 mL; anhydrous) and Et3N (3.17 
mL, 22.7 mmol).  The reaction mixture was cooled to –10 °C, and then methanesulfonyl chloride 
(1.76 mL, 22.7 mmol) was added dropwise via syringe.  After 45 min of stirring, the reaction 
mixture was filtered into a 500 mL flask to remove the white precipitate.  The flask containing 
the filtrate was flushed with nitrogen, and the solution was diluted with THF (175 mL; 
anhydrous).  Next, Pd(PPh3)4 (1.32 g, 1.14 mmol), t-BuOH (10.9 mL, 114 mmol), and 2,6-lutidine 
(6.6 mL, 57 mmol) were added sequentially.  The flask was evacuated and back-filled with CO 
(3 cycles).  After ~6 h of stirring under an atmosphere of CO, the reaction mixture was 
concentrated, and the residue was purified by column chromatography on silica gel (3% 




tert-Butyl penta-2,3-dienoate [1262883-53-3].  To an oven-dried 200 mL flask with a stir bar 
was added (tert-butoxycarbonylmethylene)triphenylphosphorane (5.00 g, 13.3 mmol).  The flask 
was evacuated and back-filled with nitrogen (3 cycles), and then CH2Cl2 (60 mL; anhydrous) 
was added, followed by Et3N (1.76 mL, 12.6 mmol).  Next, propionyl chloride (1.16 mL, 13.3 
mmol) was added as a solution in CH2Cl2 (20 mL; anhydrous) over 3 h via syringe pump.  After 
the addition was complete, the reaction mixture was stirred at room temperature for an 
additional 12 h.  Then, the mixture was concentrated to approximately 1/3 of the original 
volume, diluted with hexanes, and filtered through a plug of silica (20% EtOAc/hexanes) to 
remove much of the triphenylphosphine oxide.  The filtrate was concentrated, and the residue 
was purified by column chromatography on silica gel (5% EtOAc/hexanes), which furnished the 
title compound (565 mg, 29%) as a colorless oil. 
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III.  Catalytic Enantioselective Couplings 
 
General Procedure.  An oven-dried 4-mL vial with a stir bar was charged with catalyst 1 
(0.020 or 0.040 mmol).  The vial was capped with a PTFE-lined septum cap, wrapped with 
electrical tape, and then evacuated and backfilled with nitrogen (3 cycles).  Next, the alcohol 
(1.60 mmol) and toluene (0.40 mL; anhydrous) were added via syringe, and the reaction mixture 
was stirred.  Then, a solution of allenoate or alkynoate (0.40 mmol) in toluene (1.20 mL; 
anhydrous) was added over 16 h via syringe pump (The tip of the needle was positioned 
against the wall of the vial to ensure that the solution was added continuously rather than 
dropwise).  After the addition was complete, the reaction mixture was stirred for an additional 8 
h, and then the reaction was quenched with a solution of t-BuOOH (50 µL; 5.0–6.0 M in decane).  
The reaction mixture was stirred for 5 min, and then it was added to an aqueous solution of 
Na2S2O3 (4 mL; 10% by weight).  The organic layer was separated, and the aqueous layer was 
washed with EtOAc (4 mL x 5).  The combined organic extracts were dried over anhydrous 
Na2SO4, filtered, and concentrated.  The resulting residue was purified by column 
chromatography. 
 
Slow Addition vs. Fast Addition of the Allenoate/Alkynoate Solution.  When tert-butyl 4-
phenylbut-2-ynoate is employed as the substrate under the slow-addition conditions described 
in the General Procedure, the reaction proceeds in 94% yield with PMBOH (97% ee).  When this 
reaction is run under the same conditions except that the alkynoate solution is added in one 
portion, rather than over 16 h, the reaction proceeds with a modest decrease in yield (80% yield; 
97% ee).  For the corresponding reactions of tert-butyl 4-(thiophen-2-yl)but-2-ynoate, the yield 
drops from 90% to 16% (92% ee in both cases).  These yields were determined by 1H NMR 
spectroscopy with diphenylmethane and benzyl acetate, respectively, as an internal standard. 
Reactions Under Air vs. Reactions Under Nitrogen.  The reaction of tert-butyl 4-phenylbut-
2-ynoate with PMBOH proceeds in 89% yield and 97% ee under air, compared to 94% yield and 
97% ee under a nitrogen atmosphere.  For the corresponding couplings of tert-butyl 4-(thiophen-
2-yl)but-2-ynoate, the yield drops to 42% under air, compared with 90% under nitrogen (92% ee 
in both cases).  These yields were determined by 1H NMR spectroscopy with diphenylmethane 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-phenylbut-2-enoate (Table 1, Entry 2).  The 
title compound was synthesized according to the General Procedure from tert-butyl 4-
phenylbuta-2,3-dienoate (86.5 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 mmol), 
and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column chromatography 
on silica gel (7.5→10% Et2O/hexanes).  Colorless oil.  First run: 124 mg (87% yield), 97% ee.  
Second run ((R)-catalyst 1): 125 mg (88% yield), 94% ee. 
HPLC analysis: Daicel CHIRALPAK® AS column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 8.0 min (minor), 9.5 min (major). 
 S–9 
1H NMR (500 MHz, CDCl3) δ 7.41–7.29 (m, 5H), 7.27–7.24 (m, 2H), 6.91–6.85 (m, 3H), 6.00 
(dd, 1H, J = 1.5, 16.0 Hz), 4.94 (dd, 1H, J = 1.5, 5.5 Hz), 4.46 (d, 1H, J = 11.5 Hz), 4.39 (d, 1H, J = 
11.5 Hz), 3.81 (s, 3H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 159.4, 146.4, 139.4, 130.1, 129.5, 128.9, 128.3, 127.4, 123.0, 
114.0, 80.6, 79.6, 70.2, 55.4, 28.2. 
FT-IR (neat) 3062, 3029, 2977, 2932, 2866, 2836, 1713, 1655, 1612, 1586, 1514, 1492, 1455, 1422, 
1392, 1367, 1303, 1250, 1152, 1110, 1036, 981, 850, 822, 757 cm–1. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-phenylbut-2-enoate (Table 2, Entry 1).  The 
title compound was synthesized according to the General Procedure from tert-butyl 4-
phenylbut-2-ynoate (86.5 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 mmol), and 
(S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column chromatography on 
silica gel (7.5→10% Et2O/hexanes).  Colorless oil.  First run: 133 mg (94% yield), 96% ee.  Second 
run ((R)-catalyst 1): 134 mg (95% yield), 96% ee. 
HPLC analysis: Daicel CHIRALPAK® AS column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 8.0 min (minor), 9.5 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.41–7.29 (m, 5H), 7.27–7.24 (m, 2H), 6.91–6.85 (m, 3H), 6.00 
(dd, 1H, J = 1.5, 16.0 Hz), 4.94 (dd, 1H, J = 1.5, 5.5 Hz), 4.46 (d, 1H, J = 11.5 Hz), 4.39 (d, 1H, J = 
11.5 Hz), 3.81 (s, 3H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 159.4, 146.4, 139.4, 130.1, 129.5, 128.9, 128.3, 127.4, 123.0, 
114.0, 80.6, 79.6, 70.2, 55.4, 28.2. 
FT-IR (neat) 3062, 3029, 2977, 2932, 2866, 2836, 1713, 1655, 1612, 1586, 1514, 1492, 1455, 1422, 
1392, 1367, 1303, 1250, 1152, 1110, 1036, 981, 850, 822, 757 cm–1. 
MS (ESI) m/z (M++Na) calcd for C22H26NaO4: 377.2, found: 377.2. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(4-methoxyphenyl)but-2-enoate (Table 2, 
Entry 2).  The title compound was synthesized according to the General Procedure from tert-
butyl 4-(4-methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 
1.60 mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (10→17.5% Et2O/hexanes).  Colorless oil.  First run: 142 mg (92% 
yield), 96% ee.  Second run ((R)-catalyst 1): 137 mg (89% yield), 94% ee. 
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Gram-scale reaction (4.00 mmol scale): 1.40 g (91% yield), 94% ee.  (R)-Catalyst 1 was 
recovered as the phosphine oxide after deliberate oxidation with t-BuOOH (64.1 mg, 87%). 
HPLC analysis: Daicel CHIRALPAK® AD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 16.1 min (major), 18.3 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.27–7.21 (m, 4H), 6.93–6.84 (m, 5H), 5.97 (dd, 1H, J = 1.5, 15.5 
Hz), 4.89 (dd, 1H, J = 1.5, 5.5 Hz), 4.43 (d, 1H, J = 11.5 Hz), 4.35 (d, 1H, J = 11.5 Hz), 3.82 (s, 3H), 
3.81 (s, 3H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.9, 159.7, 159.3, 146.7, 131.4, 130.2, 129.5, 128.8, 122.8, 114.2, 
113.9, 80.6, 79.1, 69.9, 55.5, 55.4, 28.2. 
FT-IR (neat) 3001, 2976, 2865, 2836, 1711, 1653, 1611, 1586, 1513, 1457, 1442, 1420, 1392, 1368, 
1337, 1303, 1249, 1171, 1152, 1111, 1098, 1035, 981, 832, 758 cm–1. 
MS (ESI) m/z (M++Na) calcd for C23H28NaO5: 407.2, found: 407.2. 




(S,E)-tert-Butyl 4-(4-chlorophenyl)-4-((4-methoxybenzyl)oxy)but-2-enoate (Table 2, Entry 
3).  The title compound was synthesized according to the General Procedure from tert-butyl 4-
(4-chlorophenyl)but-2-ynoate (100 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 
mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (7.5→10% Et2O/hexanes).  Pale-yellow oil.  First run: 131 mg (84% 
yield), 97% ee.  Second run ((R)-catalyst 1): 129 mg (83% yield), 95% ee. 
HPLC analysis: Daicel CHIRALPAK® AD column; 1% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 9.1 min (major), 11.4 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.37–7.32 (m, 2H), 7.29–7.25 (m, 2H), 7.25–7.21 (m, 2H), 6.91–
6.86 (m, 2H), 6.82 (dd, 1H, J = 5.5, 16.0 Hz), 5.98 (dd, 1H, J = 1.5, 15.5 Hz), 4.91 (dd, 1H, J = 1.0, 5.5 
Hz), 4.44 (d, 1H, J = 11.5 Hz), 4.38 (d, 1H, J = 11.5 Hz), 3.81 (s, 3H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.6, 159.5, 145.8, 138.0, 134.1, 129.8, 129.5, 129.1, 128.8, 123.4, 
114.0, 80.8, 78.8, 70.3, 55.4, 28.2. 
FT-IR (neat) 2977, 2933, 2867, 2836, 1713, 1656, 1612, 1586, 1514, 1489, 1456, 1392, 1368, 1338, 
1303, 1250, 1153, 1111, 1089, 1036, 1015, 981, 824, 758 cm–1. 
MS (ESI) m/z (M++Na) calcd for C22H25ClNaO4: 411.1, found: 411.1. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(2-methoxyphenyl)but-2-enoate (Table 2, 
Entry 4).  The title compound was synthesized according to the General Procedure from tert-
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butyl 4-(2-methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 
1.60 mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (7.5→10% Et2O/hexanes).  Colorless oil.  First run: 115 mg (75% 
yield), 89% ee.  Second run ((R)-catalyst 1): 119 mg (77% yield), 88% ee. 
HPLC analysis: Daicel CHIRALPAK® AD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 9.7 min (major), 11.0 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.44 (dd, 1H, J = 2.0, 8.0 Hz), 7.31–7.24 (m, 3H), 7.00 (dt, 1H, J = 
1.0, 7.0 Hz), 6.93–6.85 (m, 4H), 6.01 (dd, 1H, J = 1.5, 15.5 Hz), 5.47 (dd, 1H, J = 1.5, 5.0 Hz), 4.48 (d, 
1H, J = 11.5 Hz), 4.41 (d, 1H, J = 11.5 Hz), 3.83 (s, 3H), 3.82 (s, 3H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 166.2, 159.3, 156.8, 146.3, 130.5, 129.4, 129.0, 127.7, 127.4, 122.0, 
121.1, 113.9, 110.6, 80.4, 73.6, 70.5, 55.5, 55.4, 28.2. 
FT-IR (neat) 3002, 2976, 2934, 2837, 1713, 1653, 1612, 1600, 1587, 1514, 1489, 1464, 1392, 1367, 
1340, 1302, 1287, 1247, 1152, 1093, 1032, 982, 850, 823, 756 cm–1. 
MS (ESI) m/z (M++Na) calcd for C23H28NaO5: 407.2, found: 407.2. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(o-tolyl)but-2-enoate (Table 2, Entry 5).  The 
title compound was synthesized according to the General Procedure from tert-butyl 4-(o-
tolyl)but-2-ynoate (92.1 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 mmol), and (S)-
catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column chromatography on silica 
gel (7.5→10% Et2O/hexanes).  Colorless oil.  First run: 128 mg (87% yield), 87% ee.  Second run 
((R)-catalyst 1): 127 mg (86% yield), 85% ee. 
HPLC analysis: Daicel CHIRALPAK® AD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 8.4 min (major), 9.7 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.44–7.39 (m, 1H), 7.28–7.19 (m, 4H), 7.18–7.13 (m, 1H), 6.91–
6.84 (m, 3H), 5.94 (dd, 1H, J = 1.5, 15.5 Hz), 5.16 (dd, 1H, J = 1.5, 5.0 Hz), 4.47 (d, 1H, J = 11.5 Hz), 
3.82 (s, 3H), 2.28 (s, 3H), 1.47 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.9, 159.4, 145.7, 137.2, 136.1, 130.8, 130.1, 129.5, 128.1, 127.5, 
126.6, 123.0, 114.0, 80.6, 76.7, 70.2, 55.4, 28.2, 19.4. 
FT-IR (neat) 3064, 3002, 2976, 2932, 2867, 2836, 1713, 1655, 1612, 1586, 1515, 1487, 1463, 1420, 
1392, 1367, 1339, 1302, 1249, 1210, 1152, 1111, 1090, 1036, 980, 850, 824, 751, 728 cm–1. 
MS (ESI) m/z (M++Na) calcd for C23H28NaO4: 391.2, found: 391.2. 





(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(naphthalen-1-yl)but-2-enoate (Table 2, Entry 
6).  The title compound was synthesized according to the General Procedure from tert-butyl 4-
(naphthalen-1-yl)but-2-ynoate (107 mg, 0.40 mmol), 4-methoxybenzyl alcohol (99.3 µL, 0.80 
mmol), and (S)-catalyst 1 (14.2 mg, 0.040 mmol), except that the amount of nucleophile was 
reduced from 4.0 equivalents to 2.0 equivalents and that the alkynoate solution was added by 
normal addition rather than by slow addition.  A decrease in enantioselectivity was observed 
when the reaction was run with 4.0 equivalents of nucleophile and/or when the alkynoate 
solution was added by slow addition.  The product was purified by column chromatography on 
silica gel (7.5→10% Et2O/hexanes) followed by column chromatography on reverse-phase C-18 
silica gel (10→100% CH3CN/water).  Viscous colorless oil.  First run: 105 mg (65% yield), 89% ee.  
Second run ((R)-catalyst 1): 104 mg (64% yield), 87% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 14.2 min (major), 16.3 min (minor). 
1H NMR (500 MHz, CDCl3) δ 8.16–8.11 (m, 1H), 7.92–7.87 (m, 1H), 7.85 (d, 1H, J = 8.0 Hz), 
7.58 (dd, 1H, J = 1.0, 7.0 Hz), 7.53–7.47 (m, 3H), 7.26–7.22 (m, 2H), 7.07 (dd, 1H, J = 5.0, 15.5 Hz), 
6.90–6.85 (m, 2H), 6.05 (dd, 1H, J = 2.0, 15.5 Hz), 5.63 (dd, 1H, J = 1.5, 5.0 Hz), 4.51 (d, 1H, J = 11.5 
Hz), 4.40 (d, 1H, J = 11.5 Hz), 3.81 (s, 3H), 1.43 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 159.4, 146.2, 134.9, 134.2, 131.1, 130.0, 129.6, 129.1, 129.0, 
126.4, 125.9, 125.6, 124.0, 123.2, 113.9, 110.1, 80.6, 78.0, 70.4, 55.4, 28.2. 
FT-IR (neat) 3049, 2976, 2932, 2866, 2835, 1712, 1654, 1612, 1597, 1586, 1514, 1456, 1392, 1367, 
1303, 1249, 1152, 1110, 1035, 980, 849, 822, 803, 780, 737 cm–1. 
MS (ESI) m/z (M++Na) calcd for C26H28NaO4: 427.2, found: 427.2. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(naphthalen-2-yl)but-2-enoate (Table 2, Entry 
7).  The title compound was synthesized according to the General Procedure from tert-butyl 4-
(naphthalen-2-yl)but-2-ynoate (107 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 
mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (7.5→10% Et2O/hexanes).  Pale-yellow oil.  First run: 158 mg (98% 
yield), 95% ee.  Second run ((R)-catalyst 1): 156 mg (96% yield), 94% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 14.1 min (minor), 16.2 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.89–7.82 (m, 3H), 7.79 (s, 1H), 7.54–7.45 (m, 3H), 7.29–7.24 (m, 
2H), 6.96 (dd, 1H, J = 5.5, 15.5 Hz), 6.91–6.87 (m, 2H), 6.04 (dd, 1H, J = 1.5, 15.5 Hz), 5.12 (dd, 1H, 
J = 1.5, 5.5 Hz), 4.51 (d, 1H, J = 11.0 Hz), 4.43 (d, 1H, J = 11.5 Hz), 3.82 (s, 3H), 1.47 (s, 9H). 
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13C NMR (126 MHz, CDCl3) δ 165.8, 159.4, 146.3, 136.8, 133.4, 130.1, 129.5, 128.8, 128.1, 127.9, 
126.6, 126.5, 126.4, 125.0, 123.2, 114.0, 110.1, 80.7, 79.7, 70.2, 55.4, 28.2. 
FT-IR (neat) 3056, 2976, 2931, 2865, 1711, 1653, 1612, 1586, 1513, 1456, 1392, 1367, 1303, 1249, 
1151, 1123, 1105, 1035, 981, 897, 856, 821, 752 cm–1. 
MS (ESI) m/z (M++Na) calcd for C26H28NaO4: 427.2, found: 427.2. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(thiophen-2-yl)but-2-enoate (Table 2, Entry 8).  
The title compound was synthesized according to the General Procedure from tert-butyl 4-
(thiophen-2-yl)but-2-ynoate (88.9 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 
mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (7.5% Et2O/hexanes).  Pale-yellow oil.  First run: 136 mg (94% 
yield), 93% ee.  Second run ((R)-catalyst 1): 133 mg (92% yield), 92% ee. 
HPLC analysis: Daicel CHIRALPAK® AS column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 9.5 min (minor), 12.2 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.34–7.31 (m, 1H), 7.28–7.24 (m, 2H), 7.01–6.98 (m, 2H), 6.94–
6.86 (m, 3H), 6.01 (dd, 1H, J = 1.5, 15.5 Hz), 5.19 (dd, 1H, J = 1.5, 5.5 Hz), 4.52 (d, 1H, J = 11.5 Hz), 
4.44 (d, 1H, J = 11.5 Hz), 3.81 (s, 3H), 1.48 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.6, 159.5, 145.3, 143.0, 129.7, 129.6, 126.9, 126.2, 126.0, 123.7, 
114.0, 80.8, 74.9, 70.2, 55.4, 28.2. 
FT-IR (neat) 3105, 3071, 2977, 2933, 2866, 2836, 1712, 1654, 1612, 1586, 1514, 1457, 1440, 1392, 
1368, 1302, 1251, 1153, 1097, 1036, 980, 873, 848, 824, 762, 706 cm–1. 
MS (ESI) m/z (M++Na) calcd for C20H24NaO4S: 383.1, found: 383.1. 




(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)-4-(thiophen-3-yl)but-2-enoate (Table 2, Entry 9).  
The title compound was synthesized according to the General Procedure from tert-butyl 4-
(thiophen-3-yl)but-2-ynoate (88.9 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 µL, 1.60 
mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (7.5% Et2O/hexanes).  Pale-yellow oil.  First run: 140 mg (97% 
yield), 93% ee.  Second run ((R)-catalyst 1): 138 mg (96% yield), 92% ee. 
HPLC analysis: Daicel CHIRALPAK® AS column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 10.2 min (minor), 13.5 min (major). 
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1H NMR (500 MHz, CDCl3) δ 7.33 (dd, 1H, J = 3.0, 5.0 Hz), 7.27–7.21 (m, 3H), 7.05 (dd, 1H, J = 
1.5, 5.0 Hz), 6.92–6.86 (m, 3H), 5.99 (dd, 1H, J = 1.5, 15.5 Hz), 5.05 (dd, 1H, J = 1.5, 5.5 Hz), 4.47 (d, 
1H, J = 11.5 Hz), 4.42 (d, 1H, J = 11.5 Hz), 3.81 (s, 3H), 1.48 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.7, 159.4, 145.7, 140.6, 130.0, 129.5, 126.6, 123.5, 123.0, 114.0, 
80.7, 75.5, 70.2, 55.4, 28.2. 
FT-IR (neat) 3103, 3001, 2976, 2933, 2865, 2835, 1712, 1655, 1612, 1586, 1514, 1456, 1420, 1392, 
1367, 1338, 1302, 1250, 1152, 1100, 1035, 981, 847, 824, 792, 760 cm–1. 
MS (ESI) m/z (M++Na) calcd for C20H24NaO4S: 383.1, found: 383.1. 




(S,E)-tert-Butyl-4-((4-methoxybenzyl)oxy)-4-(1-tosyl-1H-indol-5-yl)but-2-enoate (Table 2, 
Entry 10).  The title compound was synthesized according to the General Procedure from tert-
butyl 4-(1-tosyl-1H-indol-5-yl)but-2-ynoate (164 mg, 0.40 mmol), 4-methoxybenzyl alcohol (199 
µL, 1.60 mmol), and (S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column 
chromatography on silica gel (15% EtOAc/hexanes).  White solid.  First run: 198 mg (90% yield), 
92% ee.  Second run ((R)-catalyst 1): 192 mg (88% yield), 91% ee. 
HPLC analysis: Daicel CHIRALPAK® AD column; 7% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 29.5 min (major), 36.6 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.96 (d, 1H, J = 8.5 Hz), 7.79–7.75 (m, 2H), 7.58 (d, 1H, J = 3.5 
Hz), 7.49 (d, 1H, J = 1.5 Hz), 7.28–7.20 (m, 5H), 6.89–6.83 (m, 3H), 6.64 (dd, 1H, J = 0.5, 3.5 Hz), 
5.98 (dd, 1H, J = 1.5, 15.5 Hz), 4.99 (dd, 1H, J = 1.5, 5.5 Hz), 4.43 (d, 1H, J = 11.5 Hz), 4.37 (d, 1H, J 
= 12.0 Hz), 3.80 (s, 3H), 2.35 (s, 3H), 1.45 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 159.4, 146.6, 145.2, 135.3, 134.7, 134.5, 131.1, 130.1, 130.0, 
129.5, 127.02, 127.00, 124.0, 122.8, 120.3, 114.0, 113.9, 109.0, 80.7, 79.6, 70.1, 55.4, 28.2, 21.7. 
FT-IR (neat) 3142, 3114, 2977, 2932, 2867, 2837, 1713, 1652, 1612, 1596, 1514, 1456, 1372, 1303, 
1248, 1218, 1173, 1126, 1035, 995, 910, 849, 813, 768, 730 cm–1. 
MS (ESI) m/z (M++Na) calcd for C31H33NNaO6S: 570.2, found: 570.2. 




(S,E)-4-((4-methoxybenzyl)oxy)-4-(4-methoxyphenyl)-N,N-dimethylbut-2-enamide (eq 2).  
The title compound was synthesized according to the General Procedure from 4-(4-
methoxyphenyl)-N,N-dimethylbut-2-ynamide (86.9 mg, 0.40 mmol), 4-methoxybenzyl alcohol 
(199 µL, 1.60 mmol), and (S)-catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by 
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column chromatography on silica gel (65→75% EtOAc/hexanes).  Pale-yellow oil.  First run: 126 
mg (89% yield), 97% ee.  Second run ((R)-catalyst 1): 126 mg (89% yield), 96% ee. 
HPLC analysis: Daicel CHIRALPAK® AD column; 20% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 11.7 min (minor), 13.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.26–7.21 (m, 4H), 6.94–6.85 (m, 5H), 6.53 (dd, 1H, J = 1.5, 15.0 
Hz), 4.94 (dd, 1H, J = 1.5, 5.0 Hz), 4.46 (d, 1H, J = 11.5 Hz), 4.39 (d, 1H, J = 11.5 Hz), 3.81 (s, 6H), 
3.08 (s, 3H), 3.00 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 166.6, 159.6, 159.3, 145.0, 131.6, 130.3, 129.4, 128.8, 119.7, 114.1, 
113.9, 79.3, 69.9, 55.44, 55.42, 37.6, 35.8. 
FT-IR (neat) 3032, 3000, 2934, 2861, 2836, 1662, 1619, 1586, 1513, 1464, 1443, 1410, 1394, 1302, 
1249, 1173, 1144, 1111, 1094, 1058, 1033, 978, 832, 758 cm–1. 
MS (ESI) m/z (M++H) calcd for C21H26NO4: 356.2, found: 356.2. 




(R,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)pent-2-enoate (eq 3).  The title compound was 
synthesized according to the General Procedure from tert-butyl penta-2,3-dienoate (61.7 mg, 
0.40 mmol), 4-methoxybenzyl alcohol (99.3 µL, 0.80 mmol), and (S)-catalyst 1 (14.2 mg, 0.040 
mmol), except that the amount of nucleophile was reduced from 4.0 equivalents to 2.0 
equivalents and that the alkynoate solution was added by normal addition rather than by slow 
addition.  The product was purified by column chromatography on silica gel (5→10% 
Et2O/hexanes).  White solid.  First run: 110 mg (94% yield), 95% ee.  Second run ((R)-catalyst 1): 
111 mg (95% yield), 94% ee. 
HPLC analysis: Daicel CHIRALPAK® AS column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 6.9 min (minor), 9.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.29–7.23 (m, 2H), 6.90–6.85 (m, 2H), 6.77 (dd, 1H, J = 6.5, 15.5 
Hz), 5.92 (dd, 1H, J = 1.0, 15.5 Hz), 4.50 (d, 1H, J = 11.5 Hz), 4.36 (d, 1H, J = 11.0 Hz), 4.08 (doublet 
of quintets, 1H, J = 1.5, 6.5 Hz), 3.81 (s, 3H), 1.51 (s, 9H), 1.31 (d, 3H, J = 6.5 Hz). 
13C NMR (126 MHz, CDCl3) δ 165.9, 159.3, 148.3, 130.5, 129.4, 123.3, 114.0, 80.7, 73.7, 70.5, 
55.4, 28.3, 20.9. 
FT-IR (neat) 3977, 2933, 2866, 2837, 1713, 1655, 1614, 1586, 1514, 1458, 1392, 1368, 1350, 1302, 
1249, 1155, 1083, 1036, 982, 847, 824 cm–1. 
MS (ESI) m/z (M++Na) calcd for C17H24NaO4: 315.2, found: 315.2. 





(S,E)-tert-Butyl 4-(benzyloxy)-4-(4-methoxyphenyl)but-2-enoate (Table 3, Entry 2).  The 
title compound was synthesized according to the General Procedure from tert-butyl 4-(4-
methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), benzyl alcohol (166 µL, 1.60 mmol), and (S)-
catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column chromatography on silica 
gel (7.5% Et2O/hexanes).  Colorless oil.  First run: 124 mg (87% yield), 94% ee.  Second run ((R)-
catalyst 1): 126 mg (89% yield), 94% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 10.8 min (major), 12.3 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.38–7.23 (m, 7H), 6.94–6.86 (m, 3H), 6.00 (dd, 1H, J = 1.5, 15.5 
Hz), 4.92 (dd, 1H, J = 1.5, 5.5 Hz), 4.50 (d, 1H, J = 12.0 Hz), 4.43 (d, 1H, J = 12.0 Hz), 3.82 (s, 3H), 
1.47 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.9, 159.7, 146.5, 138.2, 131.3, 128.8, 128.5, 127.81, 127.79, 
122.8, 114.2, 80.6, 79.5, 70.3, 55.4, 28.2. 
FT-IR (neat) 3064, 3031, 2977, 2932, 2836, 1713, 1652, 1609, 1586, 1511, 1456, 1393, 1367, 1304, 
1250, 1151, 1099, 1035, 981, 833, 736 cm–1. 
MS (ESI) m/z (M++Na) calcd for C22H26NaO4: 377.2, found: 377.2. 





(Table 3, Entry 3).  The title compound was synthesized according to the General Procedure 
from tert-butyl 4-(4-methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), 4-
(trifluoromethyl)benzyl alcohol (110 µL, 0.80 mmol), and (S)-catalyst 1 (14.2 mg, 0.040 mmol), 
except that the amount of nucleophile was reduced from 4.0 equivalents to 2.0 equivalents.  A 
decrease in yield was observed when the reaction was run with 4.0 equivalents of nucleophile.  
The product was purified by column chromatography on silica gel (7.5→10% Et2O/hexanes).  
Colorless oil.  First run: 145 mg (86% yield), 92% ee.  Second run ((R)-catalyst 1): 145 mg (86% 
yield), 90% ee. 
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HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 7.6 min (major), 9.3 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.60 (d, 2H, J = 8.5 Hz), 7.44 (d, 2H, J = 8.0 Hz), 7.28–7.23 (m, 
2H), 6.94–6.85 (m, 3H), 6.04–5.99 (m, 1H), 4.92 (dd, 1H, J = 1.0, 5.5 Hz), 4.54 (d, 1H, J = 12.5 Hz), 
4.49 (d, 1H, J = 12.5 Hz), 3.82 (s, 3H), 1.48 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.7, 159.8, 146.1, 142.3, 130.8, 129.9 (q, JCF = 32.8 Hz), 128.7, 
127.6, 125.4 (q, JCF = 3.8 Hz), 124.3 (q, JCF = 273.3 Hz), 122.9, 114.3, 80.7, 80.0, 69.4, 55.4, 28.2. 
FT-IR (neat) 2978, 2934, 2868, 2838, 1712, 1655, 1611, 1586, 1512, 1458, 1420, 1392, 1368, 1327, 
1305, 1251, 1156, 1125, 1067, 1036, 1018, 982, 827 cm–1. 
MS (ESI) m/z (M++Na) calcd for C23H25F3NaO4: 445.2, found: 445.2. 




(S,E)-tert-Butyl 4-(allyloxy)-4-(4-methoxyphenyl)but-2-enoate (Table 3, Entry 4).  The title 
compound was synthesized according to the General Procedure from tert-butyl 4-(4-
methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), allyl alcohol (109 µL, 1.60 mmol), and (S)-
catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column chromatography on silica 
gel (7.5% Et2O/hexanes).  Colorless oil.  First run: 105 mg (86% yield), 94% ee.  Second run ((R)-
catalyst 1): 108 mg (89% yield), 93% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 6.4 min (major), 7.2 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.25–7.21 (m, 2H), 6.91–6.83 (m, 3H), 5.97 (dd, 1H, J = 1.5, 15.5 
Hz), 5.90 (tdd, 1H, J = 5.5, 10.5, 17.5 Hz), 5.27 (qd, 1H, J = 1.5, 17.0 Hz), 5.18 (qd, 1H, J = 1.5, 10.5 
Hz), 4.89 (dd, 1H, J = 1.5, 5.5 Hz), 3.98–3.88 (m, 2H), 3.80 (s, 3H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 159.7, 146.5, 134.6, 131.4, 128.6, 122.7, 117.3, 114.2, 80.6, 
79.6, 69.4, 55.4, 28.2. 
FT-IR (neat) 3078, 2978, 2933, 2836, 1711, 1654, 1648, 1610, 1586, 1512, 1457, 1420, 1392, 1368, 
1336, 1304, 1250, 1152, 1100, 1036, 982, 926, 833 cm–1. 
MS (ESI) m/z (M++Na) calcd for C18H24NaO4: 327.2, found: 327.2. 




(S,E)-tert-Butyl 4-(4-methoxyphenyl)-4-(prop-2-yn-1-yloxy)but-2-enoate (Table 3, Entry 5).  
The title compound was synthesized according to the General Procedure from tert-butyl 4-(4-
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methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), propargyl alcohol (93.1 µL, 1.60 mmol), and 
(S)-catalyst 1 (7.1 mg, 0.020 mmol).  The product was purified by column chromatography on 
silica gel (7.5→10% Et2O/hexanes).  Colorless oil.  First run: 104 mg (86% yield), 92% ee.  Second 
run ((R)-catalyst 1): 105 mg (87% yield), 90% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 9.5 min (major), 10.5 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.28–7.23 (m, 2H), 6.92–6.83 (m, 3H), 5.98 (dd, 1H, J = 1.5, 15.5 
Hz), 5.13 (dd, 1H, J = 1.5, 6.0 Hz), 4.15 (dd, 1H, J = 1.5, 16.0 Hz), 4.00 (dd, 1H, J = 2.0, 16.0 Hz), 
3.81 (s, 3H), 2.44 (t, 1H, J = 2.0 Hz), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.7, 159.9, 145.5, 130.2, 129.0, 123.4, 114.3, 80.7, 79.5, 78.7, 
74.9, 55.5, 55.4, 28.2. 
FT-IR (neat) 3291, 2977, 2934, 2838, 2117, 1713, 1653, 1610, 1586, 1512, 1457, 1442, 1392, 1368, 
1305, 1250, 1153, 1099, 1035, 981, 833 cm–1. 
MS (ESI) m/z (M++Na) calcd for C18H22NaO4: 325.2, found: 325.2. 




(S,E)-tert-Butyl 4-(2-methoxy-2-oxoethoxy)-4-(4-methoxyphenyl)but-2-enoate (Table 3, 
Entry 6).  The title compound was synthesized according to the General Procedure from tert-
butyl 4-(4-methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), methyl glycolate (61.8 µL, 0.80 
mmol), and (S)-catalyst 1 (14.2 mg, 0.040 mmol), except that the amount of nucleophile was 
reduced from 4.0 equivalents to 2.0 equivalents and that the alkynoate solution was added by 
normal addition rather than by slow addition.  A large decrease in yield was observed when the 
reaction was run with 4.0 equivalents of nucleophile or when the alkynoate solution was added 
by slow addition.  The product was purified by column chromatography on silica gel (20→30% 
Et2O/hexanes).  Yellow oil.  First run: 102 mg (76% yield), 93% ee.  Second run ((R)-catalyst 1): 96 
mg (71% yield), 93% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 2% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 17.2 min (minor), 19.2 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.28–7.23 (m, 2H), 6.92–6.85 (m, 3H), 5.99 (dd, 1H, J = 1.5, 16.0 
Hz), 5.04 (dd, 1H, J = 1.5, 5.5 Hz), 4.07 (d, 1H, J = 16.5 Hz), 4.00 (d, 1H, J = 16.5 Hz), 3.81 (s, 3H), 
3.74 (s, 3H), 1.47 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 170.7, 165.6, 160.0, 145.2, 130.1, 129.0, 123.6, 114.3, 80.70, 80.65, 
65.4, 55.5, 52.0, 28.2. 
FT-IR (neat) 3002, 2977, 2955, 2934, 2838, 1755, 1713, 1657, 1652, 1611, 1586, 1511, 1456, 1439, 
1393, 1368, 1305, 1251, 1212, 1153, 1126, 1034, 982, 834 cm–1. 
MS (ESI) m/z (M++Na) calcd for C18H24NaO6: 359.2, found: 359.2. 





(S,E)-Methyl 4-methoxy-4-(4-methoxyphenyl)but-2-enoate (Table 3, Entry 7).  The title 
compound was synthesized according to the General Procedure from methyl 4-(4-
methoxyphenyl)but-2-ynoate (81.7 mg, 0.40 mmol), methanol (65 µL, 1.60 mmol; anhydrous), 
and (S)-catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by column chromatography 
on silica gel (15→25% Et2O/hexanes).  Pale-yellow oil.  First run: 82.8 mg (88% yield), 92% ee.  
Second run ((R)-catalyst 1): 82.0 mg (87% yield), 91% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 15.6 min (minor), 18.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.24–7.19 (m, 2H), 6.96 (dd, 1H, J = 6.0, 16.0 Hz), 6.91–6.86 (m, 
2H), 6.07 (dd, 1H, J = 1.5, 15.5 Hz), 4.73 (dd, 1H, J = 1.5, 5.5 Hz), 3.80 (s, 3H), 3.72 (s, 3H), 3.30 (s, 
3H). 
13C NMR (126 MHz, CDCl3) δ 167.0, 159.8, 147.9, 131.0, 128.6, 120.3, 114.3, 82.1, 56.7, 55.5, 
51.8. 
FT-IR (neat) 2996, 2950, 2906, 2837, 1725, 1661, 1611, 1586, 1512, 1463, 1436, 1342, 1304, 1250, 
1202, 1167, 1106, 1035, 983, 834 cm–1. 
MS (ESI) m/z (M++H) calcd for C13H17O4: 237.1, found: 237.1. 




(S,E)-tert-Butyl 4-(4-methoxyphenyl)-4-(pentyloxy)but-2-enoate (Table 3, Entry 8).  The 
title compound was synthesized according to the General Procedure from tert-butyl 4-(4-
methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), 1-pentanol (174 µL, 1.60 mmol), and (S)-
catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by column chromatography on 
silica gel (5→10% Et2O/hexanes).  Colorless oil.  First run: 108 mg (81% yield), 97% ee.  Second 
run ((R)-catalyst 1): 111 mg (83% yield), 95% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 1% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 6.2 min (major), 7.2 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.25–7.20 (m, 2H), 6.91–6.86 (m, 2H), 6.85 (dd, 1H, J = 6.0, 16.0 
Hz), 5.95 (dd, 1H, J = 1.5, 16.0 Hz), 4.80 (dd, 1H, J = 1.5, 5.5 Hz), 3.80 (s, 3H), 3.41–3.30 (m, 2H), 
1.68–1.54 (m, 2H), 1.46 (s, 9H), 1.38–1.24 (m, 4H), 0.88 (t, 3H, J = 7.0 Hz). 
13C NMR (126 MHz, CDCl3) δ 165.9, 159.5, 147.0, 131.9, 128.5, 122.5, 114.1, 80.6, 80.5, 69.0, 
55.4, 29.6, 28.5, 28.2, 22.6, 14.1. 
FT-IR (neat) 2956, 2933, 2860, 1713, 1655, 1610, 1586, 1511, 1457, 1392, 1367, 1338, 1303, 1250, 
1152, 1103, 1036, 981, 832 cm–1. 
MS (ESI) m/z (M++Na) calcd for C20H30NaO4: 357.2, found: 357.2. 
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(S,E)-tert-Butyl 4-(4-methoxyphenyl)-4-(2-(trimethylsilyl)ethoxy)but-2-enoate (Table 3, 
Entry 9).  The title compound was synthesized according to the General Procedure from tert-
butyl 4-(4-methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), 2-(trimethysilyl)ethanol (229 µL, 
1.60 mmol), and (S)-catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by column 
chromatography on silica gel (5→7.5% Et2O/hexanes).  Colorless oil.  First run: 92.4 mg (63% 
yield), 95% ee.  Second run ((R)-catalyst 1): 96.2 mg (66% yield), 96% ee. 
Reactions run with 20% catalyst 1 (24.8 mg, 0.080 mmol).  First run ((S)-catalyst 1): 115 mg 
(79% yield), 94% ee.  Second run ((R)-catalyst 1): 115 mg (79% yield), 96% ee. 
HPLC analysis: Daicel CHIRALPAK® OD column; 0.3% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 6.5 min (major), 8.4 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.25–7.20 (m, 2H), 6.91–6.86 (m, 2H), 6.84 (dd, 1H, J = 5.5, 15.5 
Hz), 5.94 (dd, 1H, J = 1.0, 15.5 Hz), 4.81 (dd, 1H, J = 1.0, 5.5 Hz), 3.80 (s, 3H), 3.51–3.41 (m, 2H), 
1.46 (s, 9H), 1.02–0.86 (m, 2H), –0.02 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.9, 159.5, 147.0, 131.9, 128.5, 122.5, 114.1, 80.5, 80.3, 66.2, 
55.4, 28.2, 18.4, –1.2. 
FT-IR (neat) 2953, 2837, 1714, 1653, 1610, 1586, 1511, 1457, 1442, 1419, 1392, 1368, 1336, 1303, 
1249, 1152, 1101, 1036, 981, 942, 858, 835, 755 cm–1. 
MS (ESI) m/z (M++Na) calcd for C20H32NaO4Si: 387.2, found: 387.2. 




(S,E)-tert-Butyl 4-(cyclohexylmethoxy)-4-(4-methoxyphenyl)but-2-enoate (Table 3, Entry 
10).  The title compound was synthesized according to the General Procedure from tert-butyl 4-
(4-methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), cyclohexanemethanol (197 µL, 1.60 
mmol), and (S)-catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by column 
chromatography on silica gel (5→10% Et2O/hexanes).  White solid.  First run: 110 mg (75% 
yield), 96% ee.  Second run ((R)-catalyst 1): 109 mg (75% yield), 96% ee. 
HPLC analysis: Daicel CHIRALCEL® OD column; 0.3% 2-PrOH/hexanes; 0.8 mL/min; 
retention times: 6.5 min (major), 7.1 min (minor). 
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1H NMR (500 MHz, CDCl3) δ 7.24–7.19 (m, 2H), 6.91–6.86 (m, 2H), 6.83 (dd, 1H, J = 5.5, 15.5 
Hz), 5.95 (dd, 1H, J = 1.5, 16.0 Hz), 4.77 (dd, 1H, J = 1.5, 5.0 Hz), 3.80 (s, 3H), 3.21–3.11 (m, 2H), 
1.82–1.54 (m, 6H), 1.46 (s, 9H), 1.30–1.08 (m, 3H), 0.98–0.83 (m, 2H). 
13C NMR (126 MHz, CDCl3) δ 166.0, 159.5, 147.1, 132.0, 128.5, 122.3, 114.1, 80.6, 80.5, 74.7, 
55.4, 83.3, 30.25, 30.20, 28.2, 26.7, 26.02, 25.99. 
FT-IR (neat) 2977, 2924, 2852, 1713, 1656, 1610, 1586, 1511, 1450, 1420, 1392, 1367, 1338, 1303, 
1249, 1151, 1118, 1072, 1037, 981, 891, 832 cm–1. 
MS (ESI) m/z (M++Na) calcd for C22H32NaO4: 383.2, found: 383.2. 




(S,E)-tert-Butyl 4-(4-methoxyphenyl)-4-((S)-1-phenylethoxy)but-2-enoate (eq 5).  The title 
compound was synthesized according to the General Procedure from tert-butyl 4-(4-
methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), (S)-1-phenylethanol (193 µL, 1.60 mmol), 
and (S)-catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by column chromatography 
on silica gel (5→7.5% Et2O/hexanes).  Colorless oil.  First run: 128 mg (87% yield), >20:1 dr.  
Second run ((R)-1-phenylethanol, (R)-catalyst 1): 126 mg (85% yield), >20:1 dr. 
The dr of the reaction was determined through analysis of the unpurified reaction mixture 
by 1H NMR spectroscopy. 
HPLC analysis: Daicel CHIRALPAK® AD column; 7% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 47.1 min (major), 53.4 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.38–7.33 (m, 2H), 7.32–7.25 (m, 3H), 7.20–7.15 (m, 2H), 6.93–
6.88 (m, 2H), 6.83–6.77 (m, 1H), 5.97–5.91 (m, 1H), 4.71–4.67 (m, 1H), 4.33 (q, 1H, J = 6.5 Hz), 3.83 
(s, 3H), 1.46 (s, 9H), 1.40 (d, 3H, J = 6.5 Hz). 
13C NMR (126 MHz, CDCl3) δ 166.1, 159.7, 147.2, 143.4, 131.5, 128.9, 128.7, 127.7, 126.5, 122.0, 
114.2, 80.5, 77.0, 74.5, 55.4, 28.2, 24.6. 
FT-IR (neat) 3062, 3030, 2976, 2931, 2836, 1713, 1655, 1610, 1586, 1510, 1493, 1455, 1392, 1368, 
1302, 1285, 1250, 1153, 1098, 1035, 981, 961, 912, 834, 762 cm–1. 
MS (ESI) m/z (M++Na) calcd for C23H28NaO4: 391.2, found: 391.2. 





(S,E)-tert-Butyl 4-(4-methoxyphenyl)-4-((R)-1-phenylethoxy)but-2-enoate (eq 6).  The title 
compound was synthesized according to the General Procedure from tert-butyl 4-(4-
methoxyphenyl)but-2-ynoate (98.5 mg, 0.40 mmol), (R)-1-phenylethanol (193 µL, 1.60 mmol), 
and (S)-catalyst 1 (14.2 mg, 0.040 mmol).  The product was purified by column chromatography 
on silica gel (5→7.5% Et2O/hexanes).  Colorless oil.  First run: 99.4 mg (67% yield), >20:1 dr.  
Second run ((S)-1-phenylethanol, (R)-catalyst 1): 102 mg (69% yield), >20:1 dr. 
The dr of the reaction was determined through analysis of the unpurified reaction mixture 
by 1H NMR spectroscopy. 
HPLC analysis: Daicel CHIRALPAK® AD column; 7% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 47.1 min (major), 53.4 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.36–7.25 (m, 5H), 7.19–7.15 (m, 2H), 6.90–6.82 (m, 3H), 5.96 
(dd, 1H, J = 1.5, 15.5 Hz), 4.79 (d, 1H, J = 6.5 Hz), 4.58 (q, 1H, J = 6.5 Hz), 3.79 (s, 3H), 1.52–1.48 
(m, 12H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 159.4, 146.6, 143.6, 131.9, 128.6, 128.5, 127.6, 126.5, 123.3, 
114.1, 80.7, 77.3, 75.5, 55.4, 28.3, 24.0. 
FT-IR (neat) 3063, 3030, 2976, 2931, 2836, 1713, 1652, 1611, 1586, 1512, 1494, 1455, 1422, 1392, 
1368, 1301, 1283, 1250, 1209, 1151, 1091, 1035, 1012, 982, 910, 831, 761 cm–1. 
MS (ESI) m/z (M++Na) calcd for C23H28NaO4: 391.2, found: 391.2. 
[α]25D = +21.5° (c = 1.00, CHCl3). 
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IV.  Functionalization of the Coupling Products 
 
 
(3R,4S)-tert-Butyl 4-(4-methoxyphenyl)-4-(pentyloxy)-3-phenylbutanoate (eq 7).  The title 
compound was synthesized, according to a literature procedure for conjugate addition,2 from 
(S,E)-tert-butyl 4-(4-methoxyphenyl)-4-(pentyloxy)but-2-enoate (167 mg, 0.50 mmol), CuBr·SMe2 
(10.3 mg, 0.050 mmol), PhMgBr (3.0 M in Et2O; 500 µL, 1.50 mmol), HMPA (174 µL, 1.00 mmol), 
and TMSCl (127 µL, 1.00 mmol) in THF (anhydrous; 14.0 mL); the enoate solution was added 
over 75 min via syringe pump, and the reaction mixture was stirred at –78 °C for 24 h, and then 
at –40 °C for 12 h.  The product was purified by column chromatography on silica gel (5→10% 
Et2O/hexanes).  White solid.  204 mg (99% yield), >20:1 dr.  Second run: 196 mg (95% yield), 
>20:1 dr. 
The dr of the reaction was determined through analysis of the unpurified reaction mixture 
by 1H NMR spectroscopy. 
1H NMR (500 MHz, CDCl3) δ 7.17–7.08 (m, 3H), 7.05–7.01 (m, 2H), 6.99–6.95 (m, 2H), 6.75–
6.71 (m, 2H), 4.19 (d, 1H, J = 7.5 Hz), 3.75 (s, 3H), 3.34–3.23 (m, 2H), 3.12 (dt, 1H, J = 6.5, 9.0 Hz), 
2.98 (dd, 1H, J = 5.0, 15.5 Hz), 2.64 (dd, 1H, J = 10.5, 15.5 Hz), 1.56–1.48 (m, 2H), 1.34–1.23 (m, 
4H), 1.20 (s, 9H), 0.90–0.86 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.2, 158.8, 141.2, 133.0, 128.9, 128.4, 127.9, 126.4, 113.3, 85.5, 
80.1, 69.2, 55.3, 50.1, 38.1, 29.6, 28.6, 28.0, 22.6, 14.2. 
FT-IR (neat) 3063, 3030, 3002, 2957, 2932, 2860, 1728, 1611, 1586, 1511, 1496, 1455, 1391, 1367, 
1341, 1302, 1249, 1172, 1147, 1095, 1036, 956, 847, 830, 764, 749, 699 cm–1. 




(2S,3S,4R)-tert-Butyl 2,3-dihydroxy-4-((4-methoxybenzyl)oxy)-4-phenylbutanoate (eq 8).  
To an 8 mL vial with a stir bar was added (S,E)-tert-butyl 4-((4-methoxybenzyl)oxy)-4-
phenylbut-2-enoate (70.9 mg, 0.20 mmol), t-BuOH (0.50 mL), and water (0.50 mL).  The biphasic 
solution was stirred, and then AD-mix-β (285 mg) and methanesulfonamide (19.0 mg, 0.20 
mmol) were added in turn.  The vial was capped, and the reaction mixture was stirred for 48 h 
at room temperature.  Next, the reaction was diluted with water (0.50 mL), and then Na2SO3 
(126 mg, 1.00 mmol) was added.  The mixture was stirred for 15 min, and then it was extracted 
with EtOAc (5 mL x 4).  The combined organic extracts were dried over anhydrous Na2SO4, 
filtered, and concentrated.  The resulting residue was purified by column chromatography on 
silica gel (40→60% Et2O/hexanes).  Colorless oil.  First run: 74.7 mg (96% yield), 10:1 dr.  Second 
run: 72.0 mg (93% yield), 10:1 dr. 
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The dr of the reaction was determined through analysis of the unpurified reaction mixture 
by 1H NMR spectroscopy. 
1H NMR (500 MHz, CDCl3) δ 7.50–7.34 (m, 5H), 7.25–7.19 (m, 2H), 6.90–6.85 (m, 2H), 4.57 
(dd, 1H, J = 1.0, 5.0 Hz), 4.46 (d, 1H, J = 8.5 Hz), 4.39 (d, 1H, J = 10.5 Hz), 4.28 (d, 1H, J = 11.0 Hz), 
3.96 (dt, 1H, J = 1.5, 8.5 Hz), 3.80 (s, 3H), 3.21 (d, 1H, J = 5.0 Hz), 1.80 (d, 1H, J = 8.0 Hz), 1.47 (s, 
9H). 
13C NMR (126 MHz, CDCl3) δ 173.0, 159.4, 139.1, 130.1, 129.8, 128.8, 128.6, 128.0, 113.9, 83.1, 
81.1, 75.4, 70.9, 70.5, 55.4, 28.1. 
FT-IR (neat) 3489 (br), 3063, 3032, 2978, 2934, 2837, 1731, 1613, 1586, 1514, 1493, 1456, 1394, 
1370, 1300, 1249, 1173, 1118, 1067, 1035, 847, 822, 752, 719, 701 cm–1. 




(S,E)-tert-Butyl 4-(4-chlorophenyl)-4-hydroxybut-2-enoate (eq 9).  An 8-mL vial with a stir 
bar was charged with (S,E)-tert-butyl 4-(4-chlorophenyl)-4-((4-methoxybenzyl)oxy)but-2-enoate 
(77.8 mg, 0.200 mmol; 97% ee).  Next, CH2Cl2 (2.0 mL), water (0.11 mL), and DDQ (49.9 mg, 0.22 
mmol) were added sequentially.  The reaction mixture was stirred at room temperature for 16 h, 
and then the reaction was quenched with saturated NaHCO3 (5 mL).  The organic layer was 
separated, and the aqueous layer was extracted with CH2Cl2 (3 mL x 5).  The combined organic 
extracts were concentrated and purified by column chromatography on silica gel (5→40% 
Et2O/hexanes).  White solid.  First run: 48.3 mg (90% yield), 97% ee.  Second run ((R,E)-tert-butyl 
4-(4-chlorophenyl)-4-hydroxybut-2-enoate; 95% ee): 46.4 mg (86% yield), 95% ee. 
HPLC analysis: Daicel CHIRALPAK® AD column; 3% 2-PrOH/hexanes; 1.0 mL/min; 
retention times: 27.1 min (major), 29.2 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.36–7.31 (m, 2H), 7.31–7.26 (m, 2H), 6.88 (dd, 1H, J = 5.0, 15.5 
Hz), 6.03 (dd, 1H, J = 1.5, 15.5 Hz), 5.34–5.29 (m, 1H), 2.39 (d, 1H, J = 3.5 Hz), 1.48 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 165.8, 147.0, 139.7, 134.1, 129.0, 128.0, 122.6, 81.0, 72.9, 28.2. 
FT-IR (neat) 3419 (br), 2979, 2931, 1714, 1694, 1657, 1596, 1490, 1456, 1394, 1369, 1317, 1257, 
1153, 1091, 1040, 1015, 981, 833 cm–1. 
MS (FAB) m/z (M++H) calcd for C14H18ClO3: 269.1, found: 269.1. 
[α]25D = –49.7° (c = 1.00, CHCl3). 
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V.  Determination of the Resting State of the Catalyst 
 
In a glovebox, an oven-dried 4-mL vial was charged with catalyst (S)–1 (3.5 mg, 0.010 mmol) 
and toluene-d8 (0.2 mL).  To a second oven-dried 4-mL vial was added tert-butyl 4-(4-
methoxyphenyl)but-2-ynoate (49.3 mg, 0.20 mmol) and toluene-d8 (0.6 mL).  Next, 4-
methoxybenzyl alcohol (99.3 µL, 0.80 mmol) was added to an oven-dried NMR tube fitted with 
a septum cap, followed by the solution of catalyst (S)–1 (0.2 mL).  The NMR tube and the vial 
that contained the alkynoate solution were capped, wrapped with electrical tape, and removed 
from the glovebox.  The solution of the alkynoate was injected via syringe into the NMR tube, 
and the NMR tube was shaken to ensure complete mixing of the solution.  Then, the resting 
state of the catalyst was determined by 31P NMR spectroscopy, collecting data points every 5 
min for 80 min (32 scans, experiment time = 57 s).  One major peak was observed in the 31P NMR 
spectrum (δ –24.9), corresponding to the free phosphine (δ –24.9). 
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(R,E)-tert-Butyl 4-(4-chlorophenyl)-4-hydroxybut-2-enoate.  The title compound was 
synthesized through the use of (R)-catalyst 1.  Crystals suitable for X-ray crystallography were 
grown by dissolving the compound in a minimal amount of CH2Cl2, diluting with hexanes, and 
cooling to –20 °C. 
A suitable crystal of C14H17O3Cl was selected for analysis.  All measurements were made on a 
Bruker APEX-II CCD diffractometer at a temperature of 100 K.  Using Olex2 [1], the structure 
was solved with the ShelXS [2] structure solution program using Direct Methods and refined 
with the ShelXL [3] refinement package using Least Squares minimization.  The absolute 
stereochemistry was determined on the basis of the absolute structure parameter. 
 
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. 
Crystallogr. 2009, 42, 339. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 
3. Sheldrick, G. M. Acta Crystallogr. C 2015, 71, 3. 
 
 




Table S–1.  Crystal data and structure refinement for p16227ja.  
 
Identification code  p16227ja  
Empirical formula  C14H17O3Cl  
Formula weight  268.72  
Temperature/K  100.03  
Crystal system  monoclinic  
Space group  P21  
a/Å  6.6101(4)  
b/Å  15.6299(10)  
c/Å  13.3691(8)  
α/°  90  
β/°  96.855(3)  
γ/°  90  
Volume/Å3  1371.36(15)  
Z  4  
ρcalcg/cm3  1.302  
µ/mm-1  2.456  
F(000)  568.0  
Crystal size/mm3  0.2 × 0.1 × 0.1  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  6.658 to 158.602  
Index ranges  -8 ≤ h ≤ 8, -17 ≤ k ≤ 19, -17 ≤ l ≤ 16  
Reflections collected  29244  
Independent reflections  5731 [Rint = 0.0560, Rsigma = 0.0411]  
Data/restraints/parameters  5731/1/334  
Goodness-of-fit on F2  1.016  
Final R indexes [I>=2σ (I)]  R1 = 0.0331, wR2 = 0.0746  
Final R indexes [all data]  R1 = 0.0375, wR2 = 0.0769  
Largest diff. peak/hole / e Å-3  0.31/-0.25  




Table S–2.  Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for p16227ja. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ 
tensor. 
 
Atom x y z U(eq) 
Cl1 3214.7(12) 5130.6(5) 6291.8(5) 33.34(18) 
Cl2 -2136.7(12) 2765.5(5) 16142.9(5) 32.46(17) 
O1 1309(3) 3384.0(13) 12969.5(14) 21.0(4) 
O2 -3685(3) 4419.0(12) 22887.5(13) 19.1(4) 
O3 -5171(3) 5060.9(13) 21463.8(13) 23.6(4) 
O4 308(3) 2615.1(13) 11562.0(14) 24.7(4) 
C5 -3161(4) 2704.7(19) 17284.8(19) 22.1(5) 
C6 1968(4) 5098.1(19) 7370.1(19) 23.8(6) 
C7 -5880(4) 2978.3(18) 18265(2) 21.2(6) 
C8 -5068(4) 3039.0(18) 17354(2) 23.6(6) 
C9 1576(4) 2624.9(19) 13642(2) 23.2(6) 
C10 -8(5) 4783.3(19) 7301(2) 25.4(6) 
C11 -3613(4) 5197.8(19) 23510.4(19) 21.4(5) 
C12 287(4) 4145.1(18) 11516(2) 19.2(5) 
C13 -994(4) 4773.3(19) 8159(2) 23.4(6) 
C14 -4561(4) 3554.6(17) 21486(2) 18.5(5) 
C15 -4521(4) 4432.9(18) 21919.5(19) 17.6(5) 
C16 -30(4) 5062.8(17) 9078.8(19) 19.4(5) 
C17 -1099(4) 5025.7(17) 10026.7(18) 20.1(5) 
C18 -4788(4) 2578.3(16) 19091(2) 18.7(5) 
C19 2967(4) 5383.8(18) 8276(2) 24.1(6) 
C20 -2029(4) 2314.5(19) 18097(2) 23.4(6) 
O21 -7733(3) 2253.0(13) 19904.3(14) 26.2(4) 
O22 -556(3) 5705.7(13) 10696.0(14) 25.4(4) 
C23 -5545(4) 3393.9(18) 20577(2) 19.1(5) 
C24 636(4) 3301.5(18) 11995(2) 19.5(5) 
C25 -575(4) 4205.7(18) 10570(2) 20.3(5) 
C26 -5660(4) 2533.0(17) 20090(2) 20.2(5) 
C27 3134(5) 2011(2) 13292(3) 38.5(8) 
C28 -2350(5) 5893(2) 23074(2) 28.3(6) 
C29 1969(4) 5358.3(17) 9132.0(19) 21.2(6) 
C30 -2872(4) 2253.9(17) 18997(2) 20.8(5) 
C31 -5762(5) 5488(2) 23619(2) 28.0(6) 
C32 2367(5) 3030(2) 14648(2) 34.4(8) 
C33 -474(5) 2208(2) 13690(2) 29.8(6) 




Table S–3.  Anisotropic Displacement Parameters (Å2×103) for p16227ja. The anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
 
Atom U11 U22 U33 U23 U13 U12 
Cl1 51.9(4) 25.5(4) 26.1(3) 1.6(3) 19.3(3) 0.5(3) 
Cl2 46.2(4) 29.4(4) 24.5(3) 2.5(3) 15.4(3) -1.0(3) 
O1 25.7(9) 17(1) 20.0(9) 4.3(7) 1.5(7) 0.6(7) 
O2 24.6(9) 17(1) 15.4(8) -3.1(7) 0.5(7) 1.5(7) 
O3 30.3(10) 18.8(10) 20.2(8) -1.4(7) -2.9(7) 2.3(8) 
O4 31.3(10) 21.8(11) 22.4(9) -0.9(8) 8.5(8) -1.8(8) 
C5 30.8(14) 15.5(13) 20.7(12) -1.1(11) 6.5(11) -2.6(11) 
C6 36.1(14) 16.7(14) 20.1(12) 2.7(11) 9.4(11) 1.4(11) 
C7 22.5(12) 18.3(14) 22.4(13) -3.4(10) 0.3(10) 2.7(10) 
C8 31.1(14) 19.4(15) 18.6(12) -0.3(10) -3.9(11) 1.1(10) 
C9 28.0(13) 18.7(14) 23.2(13) 9.9(11) 4.7(10) 2.4(11) 
C10 38.3(16) 21.6(15) 15.5(12) -0.5(10) 0.0(11) -2.4(12) 
C11 29.5(13) 17.9(13) 16.2(12) -3.3(11) 0.8(10) 0.0(11) 
C12 18.2(12) 18.5(14) 21.5(12) -3.1(10) 4(1) -1.6(9) 
C13 24.8(13) 24.1(15) 20.6(13) 1.1(11) 0.1(10) -2.5(11) 
C14 18.7(12) 18.3(14) 18.9(12) -2(1) 4.1(9) 0.6(9) 
C15 15.1(11) 22.3(14) 15.6(12) -1.1(10) 2.7(9) -1.4(10) 
C16 25.6(12) 16.1(14) 16.1(11) 3.1(10) 1.1(9) 2.5(10) 
C17 22.0(12) 21.1(15) 17.0(11) -0.6(10) 1.4(9) 0.9(10) 
C18 24.5(12) 11.9(13) 19.6(12) -4.4(9) 2(1) -2.4(9) 
C19 26.9(13) 16.9(14) 28.8(14) -0.1(10) 4.9(11) 0.1(10) 
C20 23.8(13) 19.9(14) 26.9(13) 0.3(11) 4.9(11) 1.7(10) 
O21 25.8(10) 26.5(11) 27.9(10) -10.7(8) 9.7(8) -9.4(8) 
O22 32.7(10) 20.3(10) 22.8(9) -0.9(8) 1.8(8) 3.4(8) 
C23 18.5(12) 19.0(13) 20.5(12) -1.1(10) 4.8(10) 0.6(10) 
C24 20.6(12) 19.9(14) 19.3(12) 0.3(10) 7.4(10) 0.4(10) 
C25 20.9(12) 19.6(14) 21.4(12) -0.7(10) 6.3(10) -2.8(10) 
C26 22.8(12) 18.0(14) 19.3(12) -2(1) 1.3(10) -0.8(10) 
C27 37.8(17) 34.8(19) 44.9(19) 19.4(15) 13.1(15) 15.2(14) 
C28 36.7(16) 21.2(16) 27.2(14) -5.2(11) 4.9(12) -5.3(12) 
C29 26.1(13) 19.0(14) 17.8(12) -2.2(10) 0.3(10) 2.1(10) 
C30 23.3(13) 17.6(14) 20.9(12) 0.7(10) -0.6(10) 1.4(10) 
C31 35.7(16) 24.0(15) 25.4(14) -4.3(11) 7.9(12) 4.8(12) 
C32 40.8(18) 32.4(19) 26.5(15) 10.2(12) -9.4(13) -9.5(13) 
C33 34.7(16) 30.4(17) 24.7(14) 3.2(12) 5.7(12) -8.0(13) 
C34 45.6(17) 23.5(16) 21.6(14) -3.2(11) -6.7(12) 2.6(13) 
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Table S–4.  Bond Lengths for p16227ja. 
 
Atom Atom Length/Å   Atom Atom Length/Å 
Cl1 C6 1.745(3)   C11 C28 1.528(4) 
Cl2 C5 1.745(3)   C11 C31 1.515(4) 
O1 C9 1.486(3)   C11 C34 1.522(4) 
O1 C24 1.332(3)   C12 C24 1.472(4) 
O2 C11 1.472(3)   C12 C25 1.327(4) 
O2 C15 1.345(3)   C13 C16 1.391(4) 
O3 C15 1.207(3)   C14 C15 1.489(4) 
O4 C24 1.226(4)   C14 C23 1.332(4) 
C5 C8 1.378(4)   C16 C17 1.524(4) 
C5 C20 1.385(4)   C16 C29 1.393(4) 
C6 C10 1.388(4)   C17 O22 1.408(3) 
C6 C19 1.383(4)   C17 C25 1.493(4) 
C7 C8 1.391(4)   C18 C26 1.519(4) 
C7 C18 1.393(4)   C18 C30 1.384(4) 
C9 C27 1.521(4)   C19 C29 1.388(4) 
C9 C32 1.521(4)   C20 C30 1.388(4) 
C9 C33 1.512(4)   O21 C26 1.432(3) 




Table S–5.  Bond Angles for p16227ja. 
 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C24 O1 C9 121.1(2)   C23 C14 C15 120.8(2) 
C15 O2 C11 120.8(2)   O2 C15 C14 110.2(2) 
C8 C5 Cl2 119.5(2)   O3 C15 O2 125.4(2) 
C8 C5 C20 121.8(3)   O3 C15 C14 124.4(2) 
C20 C5 Cl2 118.7(2)   C13 C16 C17 120.9(2) 
C10 C6 Cl1 119.2(2)   C13 C16 C29 119.0(3) 
C19 C6 Cl1 119.4(2)   C29 C16 C17 120.1(2) 
C19 C6 C10 121.3(3)   O22 C17 C16 113.0(2) 
C8 C7 C18 120.4(3)   O22 C17 C25 108.2(2) 
C5 C8 C7 119.0(2)   C25 C17 C16 109.5(2) 
O1 C9 C27 110.7(2)   C7 C18 C26 120.2(2) 
O1 C9 C32 101.9(2)   C30 C18 C7 119.1(3) 
O1 C9 C33 109.1(2)   C30 C18 C26 120.7(2) 
C27 C9 C32 111.1(3)   C6 C19 C29 119.2(3) 
C33 C9 C27 112.6(3)   C5 C20 C30 118.3(3) 
C33 C9 C32 110.9(3)   C14 C23 C26 124.2(2) 
C13 C10 C6 118.7(2)   O1 C24 C12 110.8(2) 
O2 C11 C28 110.7(2)   O4 C24 O1 124.5(3) 
O2 C11 C31 109.5(2)   O4 C24 C12 124.7(2) 
O2 C11 C34 102.6(2)   C12 C25 C17 125.0(2) 
C31 C11 C28 112.7(3)   O21 C26 C18 108.5(2) 
C31 C11 C34 110.9(2)   O21 C26 C23 110.4(2) 
C34 C11 C28 110.0(2)   C23 C26 C18 109.7(2) 
C25 C12 C24 120.4(2)   C19 C29 C16 120.6(2) 




Table S–6.  Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for p16227ja. 
 
Atom x y z U(eq) 
H7 -7188 3211 18324 25 
H8 -5817 3307 16789 28 
H10 -671 4579 6677 30 
H12 682 4649 11887 23 
H13 -2352 4565 8119 28 
H14 -3876 3103 21863 22 
H17 -2605 5043 9825 24 
H19 4321 5595 8313 29 
H20 -708 2094 18040 28 
H21 -8315 2335 20422 39 
H22 -1259 6138 10514 38 
H23 -6217 3857 20216 23 
H25 -882 3688 10211 24 
H26 -4857 2113 20542 24 
H27A 2579 1752 12650 58 
H27B 3442 1561 13798 58 
H27C 4384 2325 13204 58 
H28A -1019 5659 22963 42 
H28B -2158 6373 23546 42 
H28C -3064 6092 22431 42 
H29 2654 5544 9759 25 
H30 -2118 1984 19560 25 
H31A -6405 5709 22972 42 
H31B -5720 5940 24129 42 
H31C -6553 5002 23827 42 
H32A 3638 3337 14583 52 
H32B 2623 2582 15160 52 
H32C 1351 3432 14848 52 
H33A -1451 2639 13864 45 
H33B -342 1758 14203 45 
H33C -960 1958 13033 45 
H34A -3299 4413 24763 47 
H34B -2454 5359 25004 47 





Me CO2t-Bu  
(S,E)-tert-Butyl 4-((4-methoxybenzyl)oxy)pent-2-enoate (eq 3).  The title compound was 
synthesized through the use of (R)-catalyst 1.  Crystals suitable for X-ray crystallography were 
grown by dissolving the compound in a minimal amount of pentane and cooling to 0 °C. 
A suitable crystal of C17H24O4 was selected for analysis.  All measurements were made on a 
Bruker APEX-II CCD diffractometer at a temperature of 100 K.  Using Olex2 [1], the structure 
was solved with the ShelXS [2] structure solution program using Direct Methods and refined 
with the ShelXL [3] refinement package using Least Squares minimization.  The absolute 
stereochemistry was determined on the basis of the absolute structure parameter. 
 
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. 
Crystallogr. 2009, 42, 339. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 






Table S–7.  Crystal data and structure refinement for jap16228. 
  
Identification code  jap16228  
Empirical formula  C17H24O4  
Formula weight  292.36  
Temperature/K  99.98  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  5.6182(5)  
b/Å  9.2260(8)  
c/Å  32.052(3)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  1661.4(3)  
Z  4  
ρcalcg/cm3  1.169  
µ/mm-1  0.665  
F(000)  632.0  
Crystal size/mm3  0.228 × 0.143 × 0.099  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  5.514 to 158.922  
Index ranges  -7 ≤ h ≤ 7, -11 ≤ k ≤ 11, -40 ≤ l ≤ 40  
Reflections collected  80740  
Independent reflections  3589 [Rint = 0.0401, Rsigma = 0.0103]  
Data/restraints/parameters  3589/0/195  
Goodness-of-fit on F2  1.065  
Final R indexes [I>=2σ (I)]  R1 = 0.0252, wR2 = 0.0631  
Final R indexes [all data]  R1 = 0.0258, wR2 = 0.0636  
Largest diff. peak/hole / e Å-3  0.12/-0.17  




Table S–8.  Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for jap16228. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ 
tensor. 
 
Atom x y z U(eq) 
O1 -8501.4(15) -1435.1(9) -1786.4(3) 19.02(18) 
O2 -7053.4(18) 715.8(10) -2022.8(3) 29.0(2) 
O3 -7740.1(18) 6789.1(10) 775.6(3) 25.2(2) 
O4 -10800.2(16) 3788.7(9) -884.2(3) 20.33(19) 
C5 -8354(2) 20.2(13) -1798.1(4) 19.2(2) 
C6 -10047(2) 655.1(14) -1493.3(4) 19.4(2) 
C7 -11987(2) 2805.5(13) -1161.1(4) 18.3(2) 
C8 -8674(2) 4069.7(12) -247.4(4) 17.9(2) 
C9 -10250(2) 2086.3(14) -1450.7(4) 18.3(2) 
C10 -13783(2) 3708.6(15) -1402.4(4) 23.0(3) 
C11 -7927(2) 5935.5(12) 429.3(4) 18.3(2) 
C12 -6632(2) 4909.2(14) -222.5(4) 20.8(2) 
C13 -10349(2) 4183.1(14) 71.4(4) 20.1(2) 
C14 -9991(2) 5095.6(14) 408.2(4) 21.2(3) 
C15 -9174(2) 3072.4(13) -608.3(4) 20.4(2) 
C16 -6246(2) 5852.8(14) 112.6(4) 20.8(2) 
C17 -4419(2) -2139.6(18) -1970.9(5) 32.6(3) 
C18 -7845(3) -3877.2(14) -1947.0(5) 28.4(3) 
C19 -7050(2) -2356.1(14) -2064.5(4) 20.4(3) 
C20 -7655(3) -2041.6(16) -2517.0(4) 28.6(3) 




Table S–9.  Anisotropic Displacement Parameters (Å2×103) for jap16228. The anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
 
Atom U11 U22 U33 U23 U13 U12 
O1 20.4(4) 17.1(4) 19.6(4) -1.1(3) 2.2(3) 2.3(3) 
O2 30.3(5) 23.7(4) 33.0(5) -0.9(4) 12.5(4) -3.1(4) 
O3 33.1(5) 21.5(4) 21.0(4) -5.4(3) -1.1(4) -2.9(4) 
O4 26.8(4) 16.3(4) 18.0(4) -1.4(3) -7.2(3) 2.6(3) 
C5 19.6(6) 18.8(6) 19.2(5) -0.5(5) -0.7(5) 0.7(5) 
C6 21.2(6) 19.9(6) 17.3(5) -0.2(4) 0.8(4) 0.0(5) 
C7 20.4(6) 18.1(5) 16.5(5) -1.2(4) -2.1(5) -0.1(5) 
C8 21.0(6) 15.9(5) 16.8(5) 1.7(4) -3.3(5) 2.9(5) 
C9 17.5(6) 21.0(6) 16.3(5) -1.1(4) -2.3(4) -0.7(5) 
C10 21.5(6) 28.0(6) 19.6(6) -1.5(5) -1.9(5) 5.4(5) 
C11 24.1(6) 14.1(5) 16.6(5) 0.8(4) -3.0(4) 1.2(4) 
C12 20.0(6) 25.0(6) 17.3(5) 1.3(5) 1.2(5) 0.5(5) 
C13 19.7(5) 19.2(5) 21.5(6) 2.0(5) -0.4(5) -2.3(5) 
C14 21.5(6) 22.3(6) 19.7(5) 1.1(5) 2.5(5) -0.3(5) 
C15 24.2(6) 18.2(5) 18.9(5) -0.4(4) -5.1(5) 3.9(5) 
C16 20.6(6) 20.2(6) 21.6(6) 1.7(5) -1.7(5) -3.6(5) 
C17 18.3(6) 36.9(8) 42.7(8) -7.3(6) -2.9(6) 4.5(6) 
C18 28.2(7) 21.3(6) 35.7(7) -2.8(6) 1.8(6) 6.3(5) 
C19 17.5(6) 22.7(6) 21.1(6) -4.1(5) 0.6(4) 5.5(5) 
C20 32.9(7) 32.1(7) 20.8(6) -4.3(5) 0.0(6) 6.5(6) 




Table S–10.  Bond Lengths for jap16228. 
 
Atom Atom Length/Å   Atom Atom Length/Å 
O1 C5 1.3457(14)   C8 C12 1.3868(18) 
O1 C19 1.4771(14)   C8 C13 1.3929(17) 
O2 C5 1.2100(16)   C8 C15 1.5044(16) 
O3 C11 1.3648(14)   C11 C14 1.3964(17) 
O3 C21 1.4304(16)   C11 C16 1.3886(17) 
O4 C7 1.4335(14)   C12 C16 1.3993(17) 
O4 C15 1.4330(14)   C13 C14 1.3837(17) 
C5 C6 1.4839(17)   C17 C19 1.5214(18) 
C6 C9 1.3324(17)   C18 C19 1.5201(19) 
C7 C9 1.5013(17)   C19 C20 1.5177(18) 
C7 C10 1.5201(17)         
 
 
Table S–11.  Bond Angles for jap16228. 
 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C5 O1 C19 121.54(10)   O3 C11 C14 115.05(11) 
C11 O3 C21 117.07(10)   O3 C11 C16 125.02(11) 
C15 O4 C7 112.76(9)   C16 C11 C14 119.92(11) 
O1 C5 C6 109.64(10)   C8 C12 C16 121.32(11) 
O2 C5 O1 125.66(12)   C14 C13 C8 121.32(12) 
O2 C5 C6 124.71(11)   C13 C14 C11 119.74(11) 
C9 C6 C5 120.90(11)   O4 C15 C8 108.15(9) 
O4 C7 C9 111.11(10)   C11 C16 C12 119.34(11) 
O4 C7 C10 106.08(10)   O1 C19 C17 110.00(10) 
C9 C7 C10 111.05(10)   O1 C19 C18 102.67(10) 
C12 C8 C13 118.34(11)   O1 C19 C20 110.05(10) 
C12 C8 C15 122.70(11)   C18 C19 C17 110.97(12) 
C13 C8 C15 118.94(11)   C20 C19 C17 112.41(12) 




Table S–12.  Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for jap16228. 
 
Atom x y z U(eq) 
H6 -10999 33 -1326 23 
H7 -12842 2051 -995 22 
H9 -9236 2687 -1613 22 
H10A -14820 4222 -1206 35 
H10B -14747 3072 -1580 35 
H10C -12940 4413 -1577 35 
H12 -5471 4842 -437 25 
H13 -11765 3623 57 24 
H14 -11145 5151 624 25 
H15A -7677 2842 -757 25 
H15B -9879 2155 -506 25 
H16 -4848 6431 123 25 
H17A -3952 -1150 -2046 49 
H17B -3478 -2833 -2133 49 
H17C -4131 -2296 -1673 49 
H18A -7525 -4046 -1650 43 
H18B -6967 -4587 -2115 43 
H18C -9554 -3979 -2000 43 
H20A -9379 -2126 -2558 43 
H20B -6836 -2739 -2697 43 
H20C -7142 -1057 -2588 43 
H21A -5691 8358 551 47 
H21B -4265 7160 811 47 




(3R,4S)-tert-Butyl 4-(4-methoxyphenyl)-4-(pentyloxy)-3-phenylbutanoate.  The title 
compound was synthesized through the use of (S)-catalyst 1.  Crystals suitable for X-ray 
crystallography were grown by dissolving the compound in a minimal amount of methanol and 
cooling to –20 °C. 
Low-temperature diffraction data (φ- and ω-scans) were collected on a Bruker AXS D8 
VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with Cu Kα 
radiation (λ = 1.54178 Å) from an IµS micro-source.  The structure was solved by direct methods 
using SHELXS [1] and refined against F2 on all data by full-matrix least squares with SHELXL-
2014 [2] using established refinement techniques [3].  All non-hydrogen atoms were refined 
anisotropically.  All hydrogen atoms were included into the model at geometrically calculated 
positions and refined using a riding model.  The isotropic displacement parameters of all 
hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked to (1.5 times for 
methyl groups). 
Compound P16308 crystallizes in the monoclinic space group P21 with two molecules in the 
asymmetric unit.  The alkyl chain on one of the two molecules was modeled as a two 
component disorder and refined with the help of similarity restraints on the 1,2- and 1,3-
distances and displacement parameters as well as enhanced rigid bond restraints for anisotropic 
displacement parameters. 
 
1. Sheldrick, G. M. Acta Crystallogr. A 1990, 46, 467. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 




One of two molecules in the asymmetric unit is shown. 
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Table S–13.  Crystal data and structure refinement for P16308. 
 
Identification code  P16308 
Empirical formula  C26H36O4 
Formula weight  412.55 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 17.2111(10) Å α = 90°. 
 b = 5.6508(3) Å β = 94.010(3)°. 
 c = 24.9451(15) Å γ = 90°. 
Volume 2420.1(2) Å3 
Z 4 
Density (calculated) 1.132 Mg/m3 
Absorption coefficient 0.591 mm-1 
F(000) 896 
Crystal size 0.500 x 0.050 x 0.050 mm3 
Theta range for data collection 2.573 to 74.490°. 
Index ranges -20<=h<=21, -6<=k<=6, -31<=l<=30 
Reflections collected 34100 
Independent reflections 9629 [R(int) = 0.0458] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7543 and 0.6456 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9629 / 196 / 596 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1 = 0.0426, wR2 = 0.0897 
R indices (all data) R1 = 0.0482, wR2 = 0.0921 
Absolute structure parameter 0.06(7) 
Extinction coefficient n/a 




Table S–14.  Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for P16308. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ tensor. 
 
Atom x y z U(eq) 
O(1) 1805(1) 5252(3) 3212(1) 24(1) 
O(2) 1922(1) 8168(3) 3830(1) 29(1) 
C(1) 1918(2) 6836(5) 2752(1) 32(1) 
C(2) 2731(2) 7858(7) 2807(1) 50(1) 
C(3) 1289(2) 8714(6) 2706(1) 48(1) 
C(4) 1824(2) 5136(6) 2279(1) 46(1) 
C(5) 1836(1) 6108(4) 3715(1) 20(1) 
C(6) 1745(1) 4179(4) 4121(1) 20(1) 
C(7) 2344(1) 4454(4) 4604(1) 18(1) 
O(3) 1350(1) 3482(3) 5185(1) 22(1) 
C(8) 2123(1) 2853(4) 5069(1) 19(1) 
C(9) 1008(1) 1800(5) 5524(1) 27(1) 
C(10) 195(1) 2619(5) 5625(1) 31(1) 
C(11) 156(1) 5012(5) 5901(1) 32(1) 
C(12) 552(2) 5073(6) 6466(1) 37(1) 
C(13) 469(2) 7445(6) 6747(1) 50(1) 
C(21) 3169(1) 3921(4) 4459(1) 21(1) 
C(22) 3341(2) 1837(5) 4196(1) 31(1) 
C(23) 4101(2) 1297(5) 4092(1) 40(1) 
C(24) 4701(2) 2812(5) 4252(2) 43(1) 
C(25) 4537(2) 4893(5) 4508(1) 42(1) 
C(26) 3776(1) 5439(5) 4613(1) 29(1) 
C(31) 2685(1) 3140(4) 5558(1) 19(1) 
C(32) 3235(1) 1431(4) 5698(1) 24(1) 
C(33) 3781(1) 1724(5) 6133(1) 28(1) 
C(34) 3774(1) 3774(5) 6434(1) 26(1) 
O(4) 4291(1) 4250(3) 6863(1) 36(1) 
C(37) 4820(2) 2388(6) 7026(1) 47(1) 
C(35) 3216(2) 5508(5) 6305(1) 27(1) 
C(36) 2678(1) 5174(4) 5875(1) 22(1) 
O(101) 7747(1) 5271(3) 11708(1) 30(1) 
O(102) 7911(1) 8447(3) 11175(1) 40(1) 
C(101) 7472(2) 6673(5) 12159(1) 40(1) 
 S–42 
C(102) 6724(2) 7951(6) 11975(1) 54(1) 
C(103) 8108(3) 8331(6) 12379(1) 60(1) 
C(104) 7312(2) 4764(6) 12568(1) 53(1) 
C(105) 7917(2) 6332(4) 11253(1) 26(1) 
C(106) 8107(1) 4560(4) 10829(1) 22(1) 
C(107) 7528(1) 4869(4) 10334(1) 17(1) 
C(108) 7740(1) 3246(4) 9872(1) 18(1) 
O(103) 8545(1) 3612(3) 9799(1) 25(1) 
C(109) 8928(7) 1790(30) 9522(9) 31(3) 
C(110) 9789(3) 2321(11) 9550(3) 31(1) 
C(111) 9999(3) 4574(10) 9259(2) 32(1) 
C(112) 9815(4) 4525(12) 8651(3) 41(2) 
C(113) 10062(5) 6768(17) 8370(4) 49(2) 
C(09B) 8808(9) 1720(30) 9477(9) 25(3) 
C(10B) 9616(4) 2414(13) 9299(3) 28(2) 
C(11B) 9585(4) 4461(13) 8899(3) 30(2) 
C(12B) 10377(4) 5099(14) 8715(3) 41(2) 
C(13B) 10354(5) 7050(20) 8304(4) 37(2) 
C(121) 6696(1) 4432(4) 10476(1) 16(1) 
C(122) 6502(1) 2372(4) 10745(1) 22(1) 
C(123) 5741(1) 1992(4) 10879(1) 26(1) 
C(124) 5168(1) 3651(5) 10746(1) 26(1) 
C(125) 5355(1) 5696(4) 10477(1) 27(1) 
C(126) 6114(1) 6077(4) 10343(1) 21(1) 
C(131) 7239(1) 3802(4) 9362(1) 18(1) 
C(132) 6612(1) 2375(4) 9193(1) 22(1) 
C(133) 6121(1) 2981(5) 8751(1) 26(1) 
C(134) 6255(2) 5019(5) 8465(1) 27(1) 
O(104) 5734(1) 5449(4) 8035(1) 40(1) 
C(137) 5848(2) 7504(6) 7720(1) 57(1) 
C(135) 6883(2) 6452(5) 8622(1) 30(1) 
C(136) 7370(2) 5827(4) 9068(1) 27(1)
 S–43 
Table S–15.  Bond lengths [Å] and angles [°] for P16308. 
 
O(1)-C(5)  1.343(3) 
O(1)-C(1)  1.477(3) 
O(2)-C(5)  1.206(3) 
C(1)-C(2)  1.512(4) 
C(1)-C(3)  1.514(4) 
C(1)-C(4)  1.521(4) 
C(2)-H(2A)  0.9800 
C(2)-H(2B)  0.9800 
C(2)-H(2C)  0.9800 
C(3)-H(3A)  0.9800 
C(3)-H(3B)  0.9800 
C(3)-H(3C)  0.9800 
C(4)-H(4A)  0.9800 
C(4)-H(4B)  0.9800 
C(4)-H(4C)  0.9800 
C(5)-C(6)  1.504(3) 
C(6)-C(7)  1.538(3) 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(21)  1.521(3) 
C(7)-C(8)  1.538(3) 
C(7)-H(7)  1.0000 
O(3)-C(8)  1.426(3) 
O(3)-C(9)  1.427(3) 
C(8)-C(31)  1.511(3) 
C(8)-H(8)  1.0000 
C(9)-C(10)  1.512(4) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.521(4) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-C(12)  1.522(4) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-C(13)  1.524(5) 
 S–44 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(21)-C(26)  1.385(3) 
C(21)-C(22)  1.389(4) 
C(22)-C(23)  1.387(4) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.378(4) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.377(4) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.387(4) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(31)-C(32)  1.379(3) 
C(31)-C(36)  1.396(3) 
C(32)-C(33)  1.395(3) 
C(32)-H(32)  0.9500 
C(33)-C(34)  1.380(4) 
C(33)-H(33)  0.9500 
C(34)-O(4)  1.372(3) 
C(34)-C(35)  1.393(4) 
O(4)-C(37)  1.432(4) 
C(37)-H(37A)  0.9800 
C(37)-H(37B)  0.9800 
C(37)-H(37C)  0.9800 
C(35)-C(36)  1.381(3) 
C(35)-H(35)  0.9500 
C(36)-H(36)  0.9500 
O(101)-C(105)  1.336(3) 
O(101)-C(101)  1.479(3) 
O(102)-C(105)  1.211(3) 
C(101)-C(103)  1.514(5) 
C(101)-C(102)  1.519(4) 
C(101)-C(104)  1.523(4) 
C(102)-H(10C)  0.9800 
 S–45 
C(102)-H(10D)  0.9800 
C(102)-H(10E)  0.9800 
C(103)-H(10F)  0.9800 
C(103)-H(10G)  0.9800 
C(103)-H(10H)  0.9800 
C(104)-H(10I)  0.9800 
C(104)-H(10J)  0.9800 
C(104)-H(10K)  0.9800 
C(105)-C(106)  1.508(3) 
C(106)-C(107)  1.541(3) 
C(106)-H(10L)  0.9900 
C(106)-H(10M)  0.9900 
C(107)-C(121)  1.520(3) 
C(107)-C(108)  1.537(3) 
C(107)-H(107)  1.0000 
C(108)-O(103)  1.425(3) 
C(108)-C(131)  1.520(3) 
C(108)-H(108)  1.0000 
O(103)-C(109)  1.428(12) 
O(103)-C(09B)  1.430(14) 
C(109)-C(110)  1.511(12) 
C(109)-H(10N)  0.9900 
C(109)-H(10O)  0.9900 
C(110)-C(111)  1.522(8) 
C(110)-H(11C)  0.9900 
C(110)-H(11D)  0.9900 
C(111)-C(112)  1.528(7) 
C(111)-H(11E)  0.9900 
C(111)-H(11F)  0.9900 
C(112)-C(113)  1.523(11) 
C(112)-H(11G)  0.9900 
C(112)-H(11H)  0.9900 
C(113)-H(11I)  0.9800 
C(113)-H(11J)  0.9800 
C(113)-H(11K)  0.9800 
C(09B)-C(10B)  1.538(13) 
C(09B)-H(09A)  0.9900 
C(09B)-H(09B)  0.9900 
 S–46 
C(10B)-C(11B)  1.526(10) 
C(10B)-H(10P)  0.9900 
C(10B)-H(10Q)  0.9900 
C(11B)-C(12B)  1.512(8) 
C(11B)-H(11L)  0.9900 
C(11B)-H(11M)  0.9900 
C(12B)-C(13B)  1.501(12) 
C(12B)-H(12C)  0.9900 
C(12B)-H(12D)  0.9900 
C(13B)-H(13D)  0.9800 
C(13B)-H(13E)  0.9800 
C(13B)-H(13F)  0.9800 
C(121)-C(126)  1.389(3) 
C(121)-C(122)  1.395(3) 
C(122)-C(123)  1.391(3) 
C(122)-H(122)  0.9500 
C(123)-C(124)  1.384(4) 
C(123)-H(123)  0.9500 
C(124)-C(125)  1.386(4) 
C(124)-H(124)  0.9500 
C(125)-C(126)  1.388(3) 
C(125)-H(125)  0.9500 
C(126)-H(126)  0.9500 
C(131)-C(136)  1.386(3) 
C(131)-C(132)  1.388(3) 
C(132)-C(133)  1.386(3) 
C(132)-H(132)  0.9500 
C(133)-C(134)  1.383(4) 
C(133)-H(133)  0.9500 
C(134)-O(104)  1.371(3) 
C(134)-C(135)  1.384(4) 
O(104)-C(137)  1.423(4) 
C(137)-H(13G)  0.9800 
C(137)-H(13H)  0.9800 
C(137)-H(13I)  0.9800 
C(135)-C(136)  1.392(4) 
C(135)-H(135)  0.9500 


























































































































































































































































































Symmetry transformations used to generate equivalent atoms  
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Table S–16.  Anisotropic Displacement Parameters (Å2×103) for P16308. The anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
 
Atom  U11 U22  U33 U23 U13 U12 
O(1)  32(1)  21(1) 18(1)  3(1) 3(1)  0(1) 
O(2)  40(1)  19(1) 27(1)  2(1) -1(1)  -2(1) 
C(1)  47(2)  29(1) 20(1)  8(1) 7(1)  1(1) 
C(2)  57(2)  58(2) 38(2)  8(2) 18(1)  -18(2) 
C(3)  73(2)  39(2) 30(2)  10(1) -5(1)  20(2) 
C(4)  74(2)  44(2) 21(1)  3(1) 6(1)  4(2) 
C(5)  16(1)  21(1) 22(1)  2(1) 0(1)  1(1) 
C(6)  20(1)  18(1) 20(1)  2(1) 1(1)  -1(1) 
C(7)  17(1)  17(1) 21(1)  1(1) 2(1)  1(1) 
O(3)  17(1)  26(1) 24(1)  8(1) 4(1)  -2(1) 
C(8)  17(1)  17(1) 24(1)  1(1) 2(1)  1(1) 
C(9)  27(1)  30(1) 25(1)  7(1) 4(1)  -6(1) 
C(10)  21(1)  46(2) 27(1)  8(1) 2(1)  -10(1) 
C(11)  23(1)  47(2) 26(1)  10(1) 8(1)  4(1) 
C(12)  3(2)  45(2) 23(1)  10(1) 7(1)  2(1) 
C(13)  68(2)  50(2) 32(2)  6(2) 10(2)  0(2) 
C(21)  20(1)  18(1) 25(1)  4(1) 4(1)  0(1) 
C(22)  24(1)  20(1) 49(2)  -3(1) 9(1)  -2(1) 
C(23)  33(2)  21(1) 67(2)  -4(1) 18(1)  4(1) 
C(24)  23(1)  28(2) 80(2)  4(2) 15(1)  4(1) 
C(25)  22(1)  33(2) 72(2)  -4(2) 9(1)  -7(1) 
C(26)  21(1)  24(1) 44(2)  -3(1) 7(1)  -3(1) 
C(31)  18(1)  18(1) 21(1)  4(1) 1(1)  0(1) 
C(32)  28(1)  21(1) 24(1)  0(1) 0(1)  3(1) 
C(33)  26(1)  26(1) 29(1)  5(1) -4(1)  5(1) 
C(34)  27(1)  30(1) 20(1)  4(1) -5(1)  -6(1) 
O(4)  39(1)  35(1) 31(1)  2(1) -15(1)  -4(1) 
C(37)  45(2)  48(2) 44(2)  8(2) -26(1)  0(1) 
C(35)  37(1)  19(1) 24(1)  0(1) -2(1)  -2(1) 
C(36)  26(1)  19(1) 22(1)  3(1) 2(1)  4(1) 
O(101)  53(1)  18(1) 19(1)  0(1) -4(1)  6(1) 
O(102)  74(1)  18(1) 25(1)  0(1) -11(1)  -1(1) 
C(101)  78(2)  23(1) 18(1)  -1(1) 2(1)  13(1) 
C(102)  94(3)  42(2) 29(2)  3(1) 12(2)  32(2) 
 S–56 
C(103)  113(3)  37(2) 26(2)  -10(2) -14(2)  -4(2) 
C(104)  103(3)  33(2) 24(1)  4(1) 13(2)  18(2) 
C(105)  40(1)  18(1) 19(1)  2(1) -10(1)  0(1) 
C(106)  23(1)  20(1) 21(1)  2(1) -4(1)  0(1) 
C(107)  19(1)  14(1) 17(1)  2(1) -1(1)  -2(1) 
C(108)  17(1)  19(1) 20(1)  1(1) 4(1)  -1(1) 
O(103)  16(1)  26(1) 33(1)  -4(1) 8(1)  2(1) 
C(109)  24(5)  25(4) 45(5)  -6(3) 5(4)  7(3) 
C(110)  18(2)  38(3) 37(3)  -7(3) 4(2)  2(2) 
C(111)  16(2)  43(3) 36(3)  -6(2) 2(2)  -2(2) 
C(112)  31(3)  51(3) 39(3)  -10(3) 0(3)  -8(3) 
C(113)  37(5)  64(4) 43(4)  -9(3) -3(4)  -18(4) 
C(09B)  13(4)  34(5) 30(5)  -4(4) 13(4)  4(3) 
C(10B)  20(3)  40(3) 25(3)  -12(3) 2(3)  7(3) 
C(11B)  20(3)  47(3) 22(3)  -9(3) 3(2)  -1(2) 
C(12B)  30(4)  62(4) 31(3)  1(3) 6(2)  -1(3) 
C(13B)  25(5)  60(5) 28(3)  -10(3) 8(3)  -15(4) 
C(121)  19(1)  16(1) 15(1)  -3(1) 0(1)  1(1) 
C(122)  23(1)  18(1) 24(1)  4(1) 3(1)  3(1) 
C(123)  29(1)  20(1) 32(1)  5(1) 10(1)  -1(1) 
C(124)  21(1)  24(1) 35(1)  0(1) 12(1)  1(1) 
C(125)  20(1)  23(1) 37(1)  3(1) 5(1)  5(1) 
C(126)  23(1)  18(1) 23(1)  4(1) 4(1)  2(1) 
C(131)  20(1)  20(1) 15(1)  -2(1) 5(1)  0(1) 
C(132)  25(1)  23(1) 19(1)  0(1) 4(1)  -4(1) 
C(133)  23(1)  34(1) 22(1)  -2(1) -1(1)  -4(1) 
C(134)  34(1)  31(1) 16(1)  -1(1) -1(1)  10(1) 
O(104)  47(1)  48(1) 24(1)  2(1) -10(1)  11(1) 
C(137)  92(3)  39(2) 36(2)  6(2) -26(2)  18(2) 
C(135)  48(2)  23(1) 19(1)  3(1) 2(1)  -1(1) 
C(136)  36(1)  22(1) 23(1)  0(1) 0(1)  -6(1)
 S–57 
Table S–17.  Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for P16308. 
 
Atom x  y  z  U(eq) 
H(2A) 2765 9035 3097 76 
H(2B) 2848 8614 2469 76 
H(2C) 3107 6588 2892 76 
H(3A) 776 7956 2698 72 
H(3B) 1333 9620 2375 72 
H(3C) 1351 9781 3016 72 
H(4A) 2194 3828 2335 69 
H(4B) 1925 5977 1948 69 
H(4C) 1291 4510 2251 69 
H(6A) 1816 2620 3950 23 
H(6B) 1213 4236 4247 23 
H(7) 2328 6133 4730 22 
H(8) 2128 1165 4948 23 
H(9A) 1326 1662 5869 33 
H(9B) 985 227 5349 33 
H(10A) -49 1421 5849 37 
H(10B) -117 2698 5277 37 
H(11A) -398 5458 5920 38 
H(11B) 402 6212 5678 38 
H(12A) 1113 4719 6445 44 
H(12B) 327 3818 6684 44 
H(13A) 731 8678 6550 75 
H(13B) 708 7345 7114 75 
H(13C) -84 7838 6757 75 
H(22) 2933 772 4087 37 
H(23) 4210 -126 3909 48 
H(24) 5223 2424 4186 52 
H(25) 4946 5959 4614 51 
H(26) 3670 6873 4792 35 
H(32) 3242 17 5492 29 
H(33) 4154 523 6222 33 
H(37A) 4525 961 7105 70 
H(37B) 5138 2875 7348 70 
H(37C) 5160 2051 6736 70 
 S–58 
H(35) 3206 6915 6513 32 
H(36) 2294 6353 5793 27 
H(10C) 6842 9235 11729 82 
H(10D) 6486 8610 12288 82 
H(10E) 6362 6834 11790 82 
H(10F) 8584 7424 12472 90 
H(10G) 7941 9124 12701 90 
H(10H) 8212 9517 12106 90 
H(10I) 6921 3660 12410 80 
H(10J) 7118 5500 12888 80 
H(10K) 7795 3904 12668 80 
H(10L) 8069 2934 10972 26 
H(10M) 8645 4811 10725 26 
H(107) 7564 6544 10209 20 
H(108) 7657 1560 9976 22 
H(10N) 8719 1716 9143 38 
H(10O) 8837 235 9691 38 
H(11C) 10063 973 9394 37 
H(11D) 9981 2457 9932 37 
H(11E) 10564 4874 9332 38 
H(11F) 9716 5915 9410 38 
H(11G) 10082 3153 8499 49 
H(11H) 9247 4298 8576 49 
H(11I) 9928 6630 7983 73 
H(11J) 9790 8132 8512 73 
H(11K) 10625 6986 8435 73 
H(09A) 8440 1473 9158 30 
H(09B) 8843 234 9687 30 
H(10P) 9954 2866 9621 34 
H(10Q) 9853 1023 9134 34 
H(11L) 9236 4026 8582 36 
H(11M) 9360 5865 9068 36 
H(12C) 10719 5593 9031 49 
H(12D) 10611 3674 8560 49 
H(13D) 10883 7371 8202 56 
H(13E) 10027 6557 7986 56 
H(13F) 10136 8478 8456 56 
H(122) 6892 1223 10836 26 
 S–59 
H(123) 5614 587 11063 32 
H(124) 4649 3389 10839 32 
H(125) 4963 6838 10384 32 
H(126) 6238 7483 10158 26 
H(132) 6518 961 9385 27 
H(133) 5691 1994 8643 32 
H(13G) 5823 8916 7946 86 
H(13H) 5440 7588 7426 86 
H(13I) 6359 7423 7571 86 
H(135) 6980 7852 8426 36 
H(136) 7801 6810 9174 32
 S–60 
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VII.  1H NMR Spectra
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